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 Research Article
 Differences in Mean Levels of Maternal Resistin Serum between
 Early Onset Preeclampsia (EOPE) and Late Onset Preeclampsia
 (LOPE)
 INTRODUCTION
 Preeclampsia is one of the major causes of morbidity
 and mortality of the mother and fetus. World Health
 Organization (WHO) reported the number of deaths caused by
 preeclampsia by 16% in developing countries
 . Preeclampsia
 resulting 3-25 fold increased risk obstetric complications
 and is the cause of 30-40% of perinatal deaths in Indonesia
 1
 .
 The incidence of preeclampsia ranges between 5-10%
 of all pregnancies
 . Incidence of preeclampsia in the United
 States, Canada and Western Europe ranges between 2-5%
 of all pregnancies and higher, 4-18% in some developing
 countries in Africa
 1
 . The incidence of preeclampsia in
 Indonesia ranged between 3-10%
 3
 .
 In Dr.M. Djamil General Hospital in Padang during the
 2
 year 2011, the incidence of preeclampsia was 8.31%, on 2012
 was 11.47% and on 2013 was 12.02%.
 Preeclampsia is divided into early onset preeclampsia
 (EOPE) (<34 weeks) and late onset preeclampsia (LOPE)
 (>34 weeks) of pregnancy based on the onset of clinical
 manifestations of preeclampsia. The EOPE and LOPE has a
 different pathogenesis. The PEAD is often associated with
 impaired uteroplacental perfusion caused by disruption of
 trophoblast invasion, while LOPE is often associated with the
 presence of extrinsic and maternal factors
 .
 Preeclampsia is a protean syndrome, in which multiple
 4,5
 organ systems can be affected compared to the others.
 Preeclampsia is mainly characterized by hypertension and
 proteinuria or may be associated with abnormalities in
 laboratory test results that renal function, hepatic or
 hemostasis after 20 weeks of pregnancy
 .
 Analysis of risk factor for preeclampsia is needed to
 1,6
 mitigate the adverse effects of preeclampsia. One among
 of these risk factor is resistin which is associated with
 inflammation and insulin resistance, so that resistin was a
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maternal risk factor that associated with LOPE
 .
 Resistin is an adipose tissue-specific secretory factor
 7
 (ADSF), a hormone secreted by adipose tissue that induces
 insulin resistance in muscle and liver. Resistin stimulated by
 inflammatory conditions that produce proinflammatory
 cytokines
 .
 Preeclampsia is associated with inflammation and insulin
 7,8
 resistance which is affected by resistin. Resistin is associated
 with late onset preeclampsia because it was a maternal
 factors, so there was an increasing of maternal resistin serum
 levels in late onset preeclampsia
 .
 Previous study reported an elevated of maternal resistin
 7,8
 serum levels associated with a systemic inflammatory
 response and insulin resistance which is both of them are
 2
 2
 increased in preeclampsia compared to normal pregnancy
 .
 The other study showed the mean of Homeostasis Model
 Assessment-Insulin Resistance (HOMA-IR) and high sensitivity
 C-reactive protein (hs-CRP) was higher in late onset
 preeclampsia than early onset preeclampsia group.
 From
 various studies on the above it could be estimated that the
 inflammatory factor and insulin resistance are associated
 with higher levels of resistin more dominant in late onset
 preeclampsia group compared to early onset preeclampsia
 group.
 The HOMA-IR could be used as an indicator of insulin
 resistance, but not for inflammatory states, contrary hs-CRP
 could be used as an indicator of inflammation, but not for
 insulin resistance. Resistin is expected to describe both of
 them, because it was associated with insulin resistance and
 inflammation
 7
 .
 MATERIALS AND METHODS
 This study is an analytical cross sectional study with
 2 0 w o me n o f e a r l y o n s e t p r e e c l a mp s i a ( E OP E ) a n d 2 0 w o me n
 of late onset preeclampsia (LOPE) who met the inclusion
 criteria and there were no exclusion criteria. The samples
 were recruited in Dr.M. Djamil General Hospital, Padang from
 July-October, 2015.
 The inclusions criteria were women who detected early
 onset preeclampsia or late onset preeclampsia in obstetrics
 emergency ward of Dr.M. Djamil General Hospital, Padang
 and willing to follow the research for taking blood samples.
 The exclusions criteria were diabetes mellitus (random blood
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sugar as >200 mg dLG
 ), had suffered coronary heart disease,
 chronic kidney disease, chronic liver disease and obesity
 (BMI before pregnancy >25 kg mG
 1
 ).
 Maternal resistin serum was examined by enzyme-linked
 2
 immunosorbent assay (ELISA) method in Biomedic Laboratory
 in Medical Faculty of Andalas University. Statistical analysis
 was conducted by using SPSS program 20th version. The data
 distribution was normal with p>0.05. The differences mean
 levels of maternal resistin serum was analyzed by using
 independent t-test.
 RESULTS
 Characteristics of research subjects: Forty patients of
 research subjects consisted 20 patients of early onset
 preeclampsia (EOPE) and 20 patients of late onset
 preeclampsia (LOPE). Mean levels of maternal age in EOPE
 group is 34.4±5.144 years, whereas in LOPE group is
 32.9±6.324 years with p = 0.416. According to maternal age
 9-12
 Table 1: Characteristics of research subjects between early onset preeclampsia and late onset preeclampsia
 Characteristics EOPE (n = 20) LOPE (n = 20) Total (%) p
 Maternal age group
 <20 years 0 (0%) 0 (0%) 0
 20-35 years 8 (40%) 10 (50%) 45 0.537
 >35 years 12 (60%) 10 (50%) 55
 Maternal age (0±SD) years 34.4±5.144 31.9±6.314 0.416
 Gravidity group
 Primigravid 6 (30%) 7 (35%) 32.5 0.744
 Miltigravid 14 (70%) 13 (65%) 67.5
 Gravidity (0±SD) 2.4±1.314 2.65±1.461 0.573
 BMI group
 Underweight 0 (0%) 0 (0%) 0
 Normoweight 14 (70%) 12 (60%) 65 0.520
 Overweight 6 (30%) 8 (40%) 35
 BMI (0±SD) 22.55±1.595 22.59±1.812 0.946
 Table 2: Mean levels of maternal resistin serum in early onset preeclampsia and
 late onset preeclampsia
 EOPE LOPE
 ---------------------- -----------------------Variable
 Mean SD Mean SD
 Maternal resistin serum (ng mLG
 1
 ) 2.526 1.603 8.891 6.219
 Table 3: Mean levels difference of maternal resistin serum in early onset
 preeclampsia and late onset preeclampsia
 Variable Mean difference CI (95%) p
 Maternal resistin serum (ng mLG
 1
 ) 6.365 3.3835-9.3475 0.000
 groups, study of subjects in early onset preeclampsia
 consists 8 patients (40%) in group of maternal age
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20-35 years old, 12 patients (60%) in group of maternal age
 >35 years old, none in group of maternal age <20 years old.
 Research subjects of late onset preeclampsia consists of 1 0
 patients (50%) in group of maternal age 20-35 years old, 10
 patients (50%) in group of maternal age >35 years old, none
 in group of maternal age <20 years old.
 Mean levels of gravidity in early onset preeclampsia
 (EOPE) group is 2.4±1.314, whereas in late onset
 preeclampsia (LOPE) group is 2.65±1.461 with p = 0.573.
 According to gravidity groups, study of subjects in early
 onset preeclampsia consists 6 patients (30%) in group of
 primigravida, 14 patients (70%) in group of multigravida.
 Research subjects of l ate onset preecl ampsi a c onsi sts of
 7 patients (35%) in group of primigravida, 13 patients (65%).
 Mean levels of Body Mass Index (BMI) in early onset
 preeclampsia (EOPE) group is 22.551±1.595, whereas in late
 onset preeclampsia (LOPE) group is 22.588±1.4812 kg mG
 with p = 0.946. According to BMI groups, study of subjects in
 EOPE consists 14 patients (70%) in group of normal
 weight, 6 patients (30%) in group of overweight, none in
 group BMI underweight. Research subjects of late onset
 preeclampsia consists 12 patients (60%) in group of normal
 weight, 8 patients (40%) in group of overweight, none in
 group BMI underweight.
 2
 3
 There were no statistically significant differences
 regarding maternal age, group of maternal age, gravidity,
 group of gravidity, BMI and group of BMI characteristic
 between those two groups with p>0.05 showed in Table 1.
 Mean levels of maternal resistin serum in early onset
 preeclampsia and late onset preeclampsia: Mean levels of
 maternal resistin serum was higher in late onset preeclampsia
 vs
 2.526±1.603 ng dLG
 than early onset preeclampsia (8.891±6.219 ng mLG
 1
 ), showed in Table 2.
 Differences in mean levels of maternal resistin serum
 between late onset preeclampsia and early onset
 preeclampsia: The data distribution was normal with
 Kolmogorov Smirnov test. Analysis was performed with
 independent t-test. Table 3 showed the differences in mean
 levels of maternal resistin serum between early onset
 preeclampsia and late onset preeclampsia as 6.365 ng mLG
 with Confidence Interval (CI) 95% 3.384-9.347. There is a high
 significant differences with p<0.001.
 DISCUSSION
 The mean levels of maternal serum resistin in early
 onset preeclampsia (EOPE) group was 2.526±1.603 ng mLG
 whereas in late onset preeclampsia (LOPE) group was
 8.891±6.219 ng mLG
 (Table 2), with a mean difference
 6.365 ng dLG
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1
 1
 , 95% CI 3.384-9.347. Statistical test showed
 p<0.001, that the mean levels of maternal serum resistin
 significantly was higher in LOPE than EOPE (Table 3).
 Resistin is a hormone secreted from adipose tissue that
 induces insulin resistance in muscle and liver. Resistin
 stimulated by inflammatory conditions that produce
 proinflammatory cytokines. Resistin contribute to the
 inflammatory disorders such as coronary heart disease,
 1
 1
 1
 chronic kidney disease and liver cirrhosis as well as insulin
 resistance in diabetes mellitus through the activation of
 proinflammatory cytokines varied which depending on the
 organs affected
 .
 Insulin resistance and inflammation were the condition
 7,8
 associated to preeclampsia. This factor related to the role of
 resistin through the release of proinflammatory cytokines.
 The relationship between resistin and preeclampsia is
 connected by those which is a maternal factor in
 preeclampsia. Therefore, resistin is associated to late onset
 preeclampsia, so the levels of maternal resistin serum was
 increased in late onset preeclampsia
 .
 Inflammation and insulin resistance have been
 7,8
 investigated, that the comparasion between HOMA-IR and
 hs-CRP in EOPE and LOPE. This study reported the results
 that mean levels of HOMA-IR and hs-CRP were higher in
 LOPE compared to EOPE (HOMA IR: 4.86±5.50 vs 3.99±5.97
 and hsCRP: 123.08±38.67 vs 26.54±34.7 mg LG
 ). This study
 suggested that the inflammatory factor and insulin resistance
 were more dominant in LOPE compared to EOPE.
 1
 A s i mi l ar r es ul t s w as r epor t ed i n whi c h t he mean l evel s
 of maternal resistin serum was higher in preeclampsia
 compared to normal pregnancy related to an increase in
 insulin resistance and the response systemic inflammation
 that happened in preeclampsia particularly late onset
 preeclampsia
 .
 A cross sectional study in which two groups of pregnant
 9-12
 women with preeclampsia (n = 15) and normal pregnancy
 (n = 23) demonstrated th mean levels of maternal resistin
 serum was higher in preeclampsia (5.68±0.41 ng mLG
 )
 compared to normal pregnancy (4. 65±0. 32 ng mLG
 ),
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p = 0.028. The mean levels of maternal resistin serum related
 to the mean of HOMA-IR and proinflammatory cytokines
 that were elevated in preeclampsia compared to normal
 pregnancy. T he mean of H OMA-I R ( 2. 5±0. 8 vs 1. 4±0. 1),
 IL-6 (6.34±1.02 vs 2.80±0.31) and TNF-" (1.89±0.18 vs
 1.23±0.10)
 .
 Another cross-sectional study on two groups of
 9
 pregnant women, which were preeclampsia (n = 29) and
 normal pregnancy (n = 30), found that mean levels of
 maternal resistin serum was higher in preeclampsia
 61.98±32.26 ng dLG
 , compared to normal pregnancy
 38.06±31.26 ng dLG
 1
 1
 , p = 0.013. Insulin resistance is thought
 related the increasing the levels of maternal resistin serum,
 because the mean of HOMA-IR was higher in preeclampsia
 compared to normal pregnancy (4:44±4:02 vs 3.99±2.82)
 .
 A cross sectional study was conducted on two groups of
 pregnant women, which are preeclampsia (n = 50) and normal
 pregnancy (n = 50). The median levels of maternal resistin
 1
 1
 10
 4
 serum were higher in preeclampsia 61 ng mLG
 compared to
 normal pregnancy 25.5 ng mLG
 1
 1
 , p = 0.033. Insulin resistance
 is thought related the increasing the levels of maternal
 resistin serum, because the median of HOMA-IR was higher in
 preeclampsia compared to normal pregnancy (4.7 vs 3.6)
 .
 A cross sectional study was conducted on two groups of
 pregnant women, which are preeclampsia (n = 16) and normal
 pregnancy (n = 22). The mean levels of maternal resistin
 serum was higher in preeclampsia (12.06±0.973 ng mLG
 )
 compared t o n ormal p regnancy ( 7. 35±1. 195 ng mLG
 ),
 p = 0.041. Inflammatory factors is thought related the
 increasing the levels of maternal resistin serum in
 preeclampsia. There was an increasing mean levels of
 TNF" in preeclampsia compared to normal pregnancy
 (15.23±0.674 vs 12.84±0.348 ng mLG
 1
 , p = 0.021)
 . Based on
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that description, there was a correlation between previous
 studies and this study
 9-12
 12
 .
 The mean levels of HOMA-IR and hs-CRP were higher in
 late onset preeclampsia than early onset preeclampsia, so
 according to those studies above, the insulin resistance and
 inflammation that were higher in late onset preeclampsia than
 early onset preeclampsia related to the levels of maternal
 resistin serum that was higher in late onset preeclampsia than
 early onset preeclampsia. It was appropriate with the results
 of this research that the mean levels of maternal resistin
 serum in late onset preeclampsia was significantly higher than
 early onset preeclampsia with p<0.001.
 CONCLUSION
 The mean levels of maternal resistin serum was higher
 significantly in late onset preeclampsia (LOPE) compared to
 early onset preeclampsia (EOPE).
 11
 1
 1
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Analyses of Nutrients and Body Mass Index as Risk Factor for Preeclampsia
 Introduction
 Preeclampsia is an important problem in obstetrics because it is still a major cause of maternal mortality
compared to bleeding and infection. Preeclampsia leads to maternal and perinatal morbidity. Preeclampsia is
also associated with high rates of preterm delivery, small for gestational ages, and perinatal death [1]. Little is
known about the patho- genesis of preeclampsia. Many factors are identified as risk factors for preeclampsia
including parity, multiple preg- nancies, age, family history of preeclampsia, obesity, his- tory of systemic
disease, and nutrition.
 Since preeclampsia is characterized by reduced perfu- sion of the placenta, oxidative stress, and endothelial dys-
function, nutrition has long been hypothesized to have a role in the etiology of preeclampsia [2]. Oxidative
stresses are proposed as the linkage between the two stages of preeclampsia. Nutrients can affect oxidative stress
by increasing or decreasing free radicals or antioxidants or by providing substrate for the formation of free
radicals. Several nutrients, particularly omega-3 (n - 3) fatty acids, antioxidants, and folic acid, have an
important roles in modulating endothelial function. It has also been suggested that nutrients such as trace
elements, fatty acids, and folic acid can contribute to insulin resistance, a risk factor for preeclampsia. In many
studies, decrease in serum magne- sium levels has been considered as the cause of patho- genesis of
preeclampsia. Minerals have an important
 influence on the health of pregnant women and growing fetus. Among them, serum or placental zinc (Zn)
concen- trations have been reported to be low in PE women. Fur- thermore, decreased levels of zinc, selenium,
and copper have been observed in patients with preeclampsia [3]. In another side, the nutrients with antioxidants
among high risk women showed a protective effect [4]. Folic acid has been hypothesized as a protective agent of
preeclampsia.
 Maternal obesity and insulin resistance are also believed to be important risk factors for the development of pla-
cental endothelial dysfunction and preeclampsia. Preven- tion of preeclampsia has remained elusive, owing
largely to their complex nature. Currently, maternal obesity in prepregnancy is one of the strongest modifiable
risk fac- tors. Recent studies have shown a relation between obesity in prepregnancy and the risk of
preeclampsia. The reason for obesity being associated with an increased risk of preeclampsia was explained by
increased levels of serum triglycerides and very low-density lipoprotein particles in obese women. This lipid
alterations have been suggested to promote oxidative stress caused by ischemia–reperfusion mechanism or
activated neutrophils, which leads to endothelial cell dysfunction [1].
 The hypothesis about nutritional status and body mass index (BMI) prepregnancy associated with preeclampsia
has intrigued us to study the risk factor for preeclampsia in Dr. M. Djamil Hospital, Padang, Indonesia.
 Methods
 This was a case–control study at the Department of Obstetric and Gynecology in Dr. M. Djamil Hospital,
Padang, Indonesia, between January and December 2013. Pregnant women after 20 weeks gestations were
included. A total of 140 patients were enrolled in this study with 70 cases and 70 controls. Cases were those
diagnosed with preeclampsia; meanwhile, controls were normotensive pregnant women without any other
comorbidity.
 After providing written informed consent, all subjects completed an interview for their nutritional status and
prepregnancy BMI after delivery. The nutritional status was assessed by Food Frequency Questionnaire (FFQ)
and then analyzed by Nutrisurvey Program. Calories, protein, fat, carbohydrates, calcium, phosphorus, zinc,
sodium, potassium, magnesium, vitamin A, folic acid, vitamin B1, vitamin B2, niacin, vitamin B6, vitamin B12,
vitamin C, and vitamin E were assessed. Maternal BMI was catego- rized into two groups: normal BMI and
abnormal BMI. Normal BMI was defined as 18.5–24.9 kg/m2. The inde- pendent samples t test was used for
nutritional status, and
 Chi-square test was used for BMI. Odds ratio (OR) with
 95% CI was calculated. A p value \0.05 was considered
 statistically significant. For the nutrition variable, if the p value \0.25 then continued by logistic regression back-
ward to assess the risk factor.
 Results
 Most of the subjects had normal weight, both in case and control groups. Table 1 shows that prevalence of
abnormal BMI was more common in the preeclampsia group com- pared with those without preeclampsia 19
(27.1%) versus
 12 (17.1%). BMI was not found as a significant risk factor in this study (p = 0.222).
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As shown in Table 2, the mean level for most of the
 variables, except calories, fat, and vitamin B1, was lower in subjects with preeclampsia than those without
preeclamp- sia. The difference for most of the subjects was also sta- tistically significant with p \ 0.05, except for
vitamin B1 and vitamin B2. Table 3 shows the risk factors for preeclampsia obtained by logistic regression
analyses. The nutrients that were significantly associated with increased risk of preeclampsia were deficiency of
vitamin E, zinc, fat, calcium, and vitamin C. Excess of calories and carbohy- drate also significantly associated
with increased risk of preeclampsia. Meanwhile, vitamin A and vitamin B1 were protective factors.
 Discussion
 The reason for obesity being associated with an increased risk of preeclampsia was explained by increased levels
of serum triglycerides, very low-density lipoproteins, and formation of small low-density lipoprotein particles in
obese women. This lipid profile was also found in women with preeclampsia. These lipid alterations have been
suggested to promote oxidative stress, caused by ische- mia–reperfusion mechanism or activated neutrophils,
which leads to endothelial cell dysfunction [1]. Moreover, dyslipidemia also can cause atherothrombosis and
induce the aggregation of the thrombocytes than can lead to coagulopathy which is a characteristic of
preeclampsia.
 Obesity is accompanied by oxidative stress. The origin of oxidative stress is proposed to be secondary to
increased free fatty acids and inflammation. It is also suggested that diet can contribute to oxidative stress.
Obese individuals have lower blood concentrations of antioxidants. This could be due to reduced dietary intake
of antioxidants, but increased consumption by reactive oxygen species is also possible [5].
 In this study, we found no relationship between BMI with preeclampsia. As mentioned before, dyslipidemia is
the important factor that can lead into preeclampsia. But our study did not assess profile lipid of the subjects.
Fur- thermore, central obesity has a higher risk of preeclampsia. Central obesity is characterized by visceral fat.
Visceral fat produces C-reactive protein (CRP), PAI-1, and leptin that contributes to oxidative stress. People with
central obesity have a higher risk to get preeclampsia. In this study, we did not assess the central obesity of the
subjects. Measures of body composition, including percent body fat, may very likely identify the obese woman
at risk of preeclampsia more accurately.
 Our study found that carbohydrate intake in preeclampsia group was significantly higher than the non-
preeclampsia group. The subjects that have higher carbo- hydrate will have lower protein level. Meanwhile,
protein is needed in the process of trophoblast invasion so the protein-energy malnutrition increases the risk of
preeclampsia. We also found that intake of proteins in preeclampsia was significantly lower in the preeclampsia
group.
 Folic acid and vitamin B12 are also a protector factors against preeclampsia. Those micronutrients play an
important role in suppressing the metabolism of homo- cysteine, whereas the excess of homocysteine was a cau-
sative factor of endothelial damage and became one of the causes of preeclampsia. In addition, folic acid-
supple- ments preconception enhance the placentation process and can prevent preeclampsia. Three earlier
cohort studies assessed the effect of folic acid containing multivitamins (including folic acid) and gestational
hypertension (in- cluding preeclampsia), and all showed a protective effect of folic acid supplementation on
preeclampsia [2, 6, 7].
 Table 1 Asssociation between body mass index and the risk of preeclampsia
 BMI
 Preeclampsia
 %
 Non-preeclampsia
 %
 p*
 OR
 CI 95%
 Min.
 Max.
 Abnormal BMI
 19
 27.1
 12
 17.1
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0.222
 1.801
 0.797
 4.067
 Normal BMI
 51
 72.9
 58
 82.9
 70
 100
 70
 100
 BMI body mass index, OR odds ratio, CI confidence interval
 * p value were obtained by Chi-square
 Table 2 Differences of mean nutritions level in preeclampsia and non-preeclampsia group
 Preeclampsia
 Mean (95% CI)
 Non-preeclampsia
 Mean (95% CI)
 p*
 Calorie (Kcal)
 1269.22 (745.2–2214)
 1171.15 (649.1–2447.6)
 0.048
 Protein (g)
 42.37 (23.03–95.42)
 54.9 (24.2–200.6)
 0.000
 Fat (g)
 26.8 (4.65–58.9)
 32.4 (10.79–93.12)
 0.009
 KH (g)*
 219.5 ± 56.8
 163.49 ± 46.5
 0.000
 Calcium (mg)
 234.7 (63.7–758.3)
 9362.9 (63.7–922.4)
 0.000
 Phosphor (mg)
 589.4 (296.5–1444.5)
 714.6 (324.6–2353.4)
 0.006
 Fe (mg)
 9.4 (2.84–23.9)
 11.06 (2.84–35.6)
 0.005
 Zinc (mg)
 4.8 (2.39–12.87)
 5.5 (2.4–16.5)
 0.005
 Natrium (mg)
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299.3 (76.9–970.24)
 533.3 (105.9–1847.60)
 0.000
 Kalium (mg)*
 595.4 ± 237.2
 732.15 ± 367.8
 0.010
 Magnesium (mg)
 181.1 (97.1–370.14)
 210.0 (97.1–554.5)
 0.010
 Vitamin A (lg)
 544.9 (174.9–1567.4)
 763.9 (174.9–3354.5)
 0.000
 Folic acid (lg)
 108.6 (56.8–421.6)
 163.5 (56.83–497.9)
 0.000
 Vitamin B1 (mg)
 0.7 (0.27–2.15)
 0.65 (0.27–2.01)
 0.085
 Vitamin B2 (mg)
 0.94 (0.25–2.45)
 1.1 (0.25–2.7)
 0.046
 Niacin (mg)
 4.3 (0.6–11.9)
 5.8 (2.1–23.7)
 0.000
 Vitamin B6 (mg)
 1.1 (0.66–2.14)
 1.22 (0.67–3.8)
 0.009
 Vitamin B12 (mg)
 1.1 (0.15–9.15)
 2.8 (0.27–21.1)
 0.000
 Vitamin C (mg)
 43.4 (8.4–136.8)
 68.2 (19.2–262.7)
 0.000
 Vitamin E (mg TE)
 1.9 (0.2–4.4)
 3.6 (1.8–8.2)
 0.000
 CI confidence interval
 * p value was obtained by independent samples t test
 A recent large cohort study from Denmark also showed that regular use of folic acid in pregnancy was related to
a reduced risk of preeclampsia among normal-weight women [8]. But in this study, we did not found the folic
acid and vitamin B12 as a protective agent of preeclampsia. The different result maybe caused by
supplementation that has been done generally. In other side, the no supplementation subject was rare so that
selection bias/confounding become difficult to control.
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The previous study showed that vitamin B6 deficiency is associated with cardiovascular disease. This is related
to the function of B6 for the establishment of pyridoxal 5 phosphate which is an essential coenzyme in many
meta- bolism processes. The coenzyme deficiency will lead to the diseases such as preeclampsia. Another
micronutrients that play a role in the occurrence of preeclampsia is magne- sium. In a study, obtained serum
magnesium levels in patients with preeclampsia were significantly lower than normal pregnancy. This indicates
that magnesium as one of the predictors of preeclampsia. Magnesium also allegedly acted as a coenzyme
intracellular and functions to maintain contraction and vascular tone [2].
 Serum zinc, calcium, and magnesium levels have been compared between preeclamptic and healthy pregnant
women in various studies. Some results showed that copper, zinc, and
 calcium levels were significantly lower in preeclamptic patient, whereas magnesium concentrations showed no
sig- nificant differences between the two groups [9]. Our study is consistent with that study, whereas we found
zinc and calcium deficiency as a risk factor for preeclampsia (OR 99.46, 95% CI
 1.37, 7219; OR 31, 95% CI 1.21, 841).
 Our study found that vitamin E and A deficiency increase the risk of preeclampsia (OR 19.57, 95% CI
 2.5, 151, OR 1768, 95% CI 10.22, 305,890). Antioxi-
 dants are important in maintaining cellular integrity in a normal pregnancy by inhibiting peroxidation reaction
and thus protecting enzymes, proteins, and cells from destruction by peroxides. Antioxidant defense mecha-
nisms include cellular and extracellular enzymes such as free radical scavengers, including vitamin C and E, and
metabolites such as bilirubin and uric acid. Vitamin C and E are antioxidants derived from the diet. Vitamin C
scavenges free radicals in the aqueous phase, and the lipid-soluble vitamin E acts in vivo to prevent the for-
mation of lipid peroxides and thus protect cell mem- branes. There is evidence of oxidative stress in women with
established preeclampsia, including increased plasma concentration of 8-epi-prostaglandin F2a, lipid peroxides,
and decreased concentrations of antioxidants such as vitamins C and E [10].
 Table 3 Results of multivariate logistic regression analysis
 OR p 95% confidence interval
 Calorie
 3.87
 0.028
 2.39 ± 6,268,293
 Protein
 0.049
 0.650
 0.27 ± 12,994
 Fat
 59.182
 0.138
 3.14 ± 500
 KH
 52.9
 0.063
 0.801 ± 3495
 Calcium
 109
 0.119
 0.29 ± 40,041
 Fe
 9.84
 0.149
 0.441 ± 219
 Zinc
 99.4
 0.035
 1.37 ± 7219
 Natrium
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0.62
 0.731
 0.041 ± 9.37
 Kalium
 0.005
 0.054
 0.000 ± 1.08
 Magnesium
 0.015
 0.528
 0.000 ± 7321
 Vitamin A
 0.002
 0.055
 0.000 ± 1.14
 Folic acid
 42.9
 0.193
 0.15 ± 12,383
 Vitamin B1
 0.000
 0.009
 0.000 ± 0.014
 Vitamin B2
 3.75
 0.550
 0.049 ± 285
 Niacin
 2.39
 0.068
 0.571 ± 1E ? 007
 Vitamin B6
 0.299
 0.591
 0.004 ± 24.3
 Vitamin B12
 4.511
 0.243
 0.36 ± 56.4
 Vitamin C
 19.5
 0.004
 2.52 ± 151
 Vitamin E
 1.76
 0.004
 10.2 ± 30.5
 OR odds ratio
 Conclusions
 Deficiency of vitamin E, zinc, fat, calcium, and vitamin C, and excess of calories and carbohydrate were
associated with increased risk of preeclampsia.
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Differences in Malondialdehyde and Catalase Activity Levels
 Between Abortion and Normal Pregnancy
 INTRODUCTION
 Abortion is defined as a termination of a pregnancy before
 20 weeks of gestation or when the fetal weight is less than
 500 g. Clinically, the most frequent abortion encountered in the hospital is incomplete abortion. Patients usually
come with bleeding and severe abdominal pain. The second one is threatened abortion. Threatened abortion is
the most common complication in the first half of pregnancy and have incidence about 20-25%. Less than 30%
of the women who experience threatened abortion will end in spontaneous abortion1.
 There are many factors that associated with abortion, so it is hard to determine the exact mechanism. In spite of
many possibilities, there is now a clear evidence that abortion is associated with placental oxidative stress. The
abnormal placentation will lead to placental oxidative stress with resultant destructive effects on the
syncytiotrophoblast. The theory has been proposed as a mechanism involved in the etiopathogenesis of
abortion2.
 The body has many antioxidant systems to defend the excessive Reactive Oxygen Species (ROS) production3.
In a healthy body, ROS and antioxidant remain in balance. When the body has an excessive amount of ROS,
Oxidative Stress (OS) then occurs. An increase in the expression of oxidative stress marker in the trophoblast
was detected in abortion and this was speculated to be a cause of early pregnancy loss4.
 Antioxidant system divided into enzymatic and nonenzymatic group. Catalase (CAT) is one of enzymatic
antioxidant that can remove hydrogen peroxide (H2O2), prevents lipid peroxidation in the cell membrane and
works as free radicals binding5. The CAT role in pregnancy is very important, in early pregnancy CAT plays a
role for implantation by protecting the blastocysts from superoxide radicals in the endometrium. The CAT is also
important for embryonic development and the maintenance of early pregnancy. The CAT level was found
increased during pregnancy and low CAT activity in plasma or placenta found in cases of spontaneous abortion6.
Another study also suggests that low antioxidant level increases the risk of spontaneous abortion7.
 Free radicals are thus highly unstable molecules that have electrons available to react with a various organic
substrate such as lipids, proteins and DNA8. Accumulation of lipid peroxides may cause not only tissue damage
but also some biological events to accelerate the termination of pregnancy. It has been reported that ROS or lipid
peroxide stimulate synthesis of PGF2α that causes uterine contraction6. Oxidative stress has been variably
determined by many ways. The most reliable assessment of free radicals synthesis is using assays directly to
detect the superoxide or other free radical. However, this technique is difficult and require specialized document.
In another side, measurement of the products of oxidative modification product provides the most direct and
possible assessment of oxidative stress. Malondialdehyde
 (MDA) is a metabolite of lipid peroxides that detectable in plasma and was used as an indicator of lipid
peroxidation9. This study was carried out to estimate the mean difference of CAT and MDA in normal
pregnancy, threatened abortion and incomplete abortion.
 MATERIALS AND METHODS
 This was an observational study with cross-sectional design on February-December, 2014. The population was
all pregnant women before 20 weeks gestations were enrolled in the maternity ward of Dr. M. Djamil Hospital
and Dr. Reksodiwiryo Hospital, Padang, Indonesia. Subjects were taken by consecutive sampling method. Cases
were those diagnosed with threatened and incomplete abortion by a specialist doctor. Meanwhile, controls were
normal pregnant women without any other comorbid.
 Exclusion criteria were a mother with hydatidiform mole, uterus disorder, myoma, history of provocating and
recurrent abortion. After providing informed, written consent, subject’s blood was taken from antecubital vein
for analyzed the CAT activity and MDA concentration with spectrophotometry method in Biomedical
Laboratory of Medical Faculty of Andalas University.
 The significant difference among the three groups was analyzed with ANOVA test. If p<0.05 was found, then
the analysis continued with post hoc multiple comparison test to determined the differences between two group.
Statistical analysis was conducted using a computer program.
 RESULTS
 During the study period, 42 blood samples were collected, consisting of 14 subjects with threatened abortion,
 14 subjects with incomplete abortion and 14 subjects with normal pregnancy before 20 weeks gestations. Table 1
shows the activity of CAT enzyme in incomplete abortion group was
 51.10±12.20 IU mgG1, the threatened abortion group was
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66.46±9.11 IU mgG1, whereas normal pregnancy group was
 78.26±8.88 IU mgG1. The analysis with statistical tests ANOVA found that p<0.001. To saw the specific
difference between two subjects, the analysis continued by post hoc multiple comparisons test. As presented in
Table 2, there were significant differences of CAT activity between incomplete abortion group and threatened
abortion (p<0.001), incomplete abortion and normal pregnancy (p<0.001), threatened abortion and normal
pregnancy (p = 0.01).
 Table 1: Difference of catalase activity in incomplete abortion, threatened
 abortion and normal pregnancy Catalase activity
 Parameters Mean±SD (IU mgG1) 95% CI p-value*
 Incomplete abortion 51.10±12.20 44.06-58.15 <0.001
 Threatened abortion 66.46±9.11 61.20-71.72
 Normal pregnancy 78.26±8.88 73.13-83.38
 *p-values are obtained by ANOVA test, SD: Standard deviation, CI: Confidence interval
 Table 2: Post hoc test for the difference of the mean level of catalase activity
 in incomplete abortion, threatened abortion and normal pregnancy Incomplete Threatened Normal
 Parameters abortion abortion pregnancy
 Incomplete abortion - <0.001* <0.001* Threatened abortion <0.001* - 0.01* Normal pregnancy <0.001* 0.01* -
 *p-value obtained by Tukey’s test to determine the difference between two groups
 Table 3: Difference of malondialdehyde level in incomplete abortion,
 threatened abortion and normal pregnancy Malondialdehyde level
 Parameters Mean±SD (nmol mLG1) 95% CI p-value*
 Incomplete abortion 4.02±0.36 3.81-4.23 <0.001
 Threatened abortion 3.46±0.39 3.24-3.68
 Normal pregnancy 2.83±0.21 2.71-2.96
 *p-values are obtained by ANOVA test, SD: Standard deviation, CI: Confidence interval
 Table 4: Post hoc Test for the difference of the mean level of malondialdehyde in incomplete abortion,
threatened abortion and
 normal pregnancy Incomplete Threatened Normal
 Parameters abortion abortion pregnancy
 Incomplete abortion - <0.001* <0.001* Threatened abortion <0.001* - <0.001* Normal pregnancy <0.001*
<0.001* -
 *p-value obtained by Tukey’s test to determine the difference between two groups
 As presented in Table 3, the mean level of MDA in incomplete abortion group was 4.02±0.36 nmol mLG1, the
threatened abortion group was 3.46±0.39 nmol mLG1, whereas in normal pregnancy group was 2.83±0.21 nmol
mLG1 with p = 0.00 by ANOVA test. To saw the difference between two group analysis continued with post hoc
test. According to the Table 4, it was found that there were significant differences of MDA level between
incomplete abortion with threatened abortion (p<0.001), incomplete abortion and normal pregnancy group
(p<0.001), threatened abortion and normal pregnancy (p<0.001).
 DISCUSSION
 In this study, it was found that the mean of MDA level of incomplete abortion was higher than threatened
abortion and normal pregnancy (p<0.05). Meanwhile, the mean level of CAT activity was lower in incomplete
abortion than threatened abortion and normal pregnancy (p<0.05).
 This study was accordance with a study conducted by Abdul-Barry et al.8 that found the serum MDA level was
significantly higher in patients with a history of recurrent spontaneous abortion than women with a healthy
pregnancy. Ozkaya et al.10 also reported that the spontaneous abortion before 8 weeks gestation was associated
with higher serum of MDA than healthy pregnancy (66.4±13.7 vs. 40.3±16.1, p<0.01). Because MDA is a side
product of lipid peroxidation, the increase in MDA level may reflect an overproduction of lipid peroxides and
alter antioxidant defend mechanism.
 Jauniaux et al.11 suggested the theory of how the free radical is higher in abortion than in normal pregnancy.
They found that the intervillous O2 flow appeared much earlier in the abortion group so it can lead to excessive
free radicals production that can cause abortion11.
 The oxidative stress during pregnancy occurs in response to the fetoplacental energy demand. How the oxidative
stress cause an abortion have been studied by other study. Many mechanisms have been proposed as the theory.
Zhu et al.12, suggested three factors that has an impact on the pathogenesis of abortion. First, the ROS can cause
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the lipid peroxidation injury in the embryo. Second, the increasing free radicals can change oxygen partial
pressure in embryonic cells. And the last, increased of free radicals can lead to ischemia-reperfusion injury in the
fetus12.
 Actually, increased of antioxidants activity also found in early healthy pregnancy. These indicate that the
oxidative stress actually also occurs in normal pregnancy but the sufficient antioxidants are defended the free
radicals and prevented the damage6,13,14. In this study, the mean activity of CAT enzyme of incomplete
abortion was lower than normal pregnancy and threatened abortion (p<0.05). It means that there were
differences between the CAT enzyme activity in incomplete abortion, threatened abortion and normal pregnancy.
It was suggested that the excess of free radicals and the decreased of antioxidants in this study were associated
with the abortion.
 Sugino et al.6 found that CAT total activity was decrease
 and prostaglandin F2α synthesis was increase in decidua in cases of spontaneous abortion with vaginal bleeding.
They proposed that the termination of pregnancy was caused by decreasing activity of CAT which stimulates the
synthesis of prostaglandins6. This study was accordance with the study by Yigenoglu et al.15 that found the total
antioxidant capacity is lower in pregnant women with history of spontaneous abortion than healthy pregnant
women. It also accordance with a study conducted by Biri et al.16 that found the CAT activity was higher in
abortion group than in control group (87.62±8.19 vs
 44.47±3.79 IU mgG1).
 CONCLUSION
 Abortion group had lower antioxidant concentration and higher free radicals than normal pregnancy. There was
an imbalance of free radical and antioxidant concentration in abortion.
 SIGNIFICANT STATEMENT
 The imbalance of free radical and antioxidant has been proposed to one of many theories that can cause abortion.
This study tried to determine the comparison of antioxidant and free radical level by analyzed the catalase
activity and malondialdehyde concentration in normal pregnancy and
 abortion. Malondialdehyde (MDA) is a metabolite of lipid peroxides that used as an indicator of lipid
peroxidation as a free radical. Meanwhile, catalase is one of antioxidant that works as free radicals binding by
preventing lipid peroxidation in the cell membrane. The result of this study will determine the imbalance of free
radicals and antioxidants in abortion and will help the medical field to develop the prevention of abortion.
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Analyses of Nutrients and Body Mass Index as Risk Factor for Preeclampsia
 Introduction
 Preeclampsia is an important problem in obstetrics because it is still a major cause of maternal mortality
compared to bleeding and infection. Preeclampsia leads to maternal and perinatal morbidity. Preeclampsia is
also associated with high rates of preterm delivery, small for gestational ages, and perinatal death [1]. Little is
known about the patho- genesis of preeclampsia. Many factors are identified as risk factors for preeclampsia
including parity, multiple preg- nancies, age, family history of preeclampsia, obesity, his- tory of systemic
disease, and nutrition.
 Since preeclampsia is characterized by reduced perfu- sion of the placenta, oxidative stress, and endothelial dys-
function, nutrition has long been hypothesized to have a role in the etiology of preeclampsia [2]. Oxidative
stresses are proposed as the linkage between the two stages of preeclampsia. Nutrients can affect oxidative stress
by increasing or decreasing free radicals or antioxidants or by providing substrate for the formation of free
radicals. Several nutrients, particularly omega-3 (n - 3) fatty acids, antioxidants, and folic acid, have an
important roles in modulating endothelial function. It has also been suggested that nutrients such as trace
elements, fatty acids, and folic acid can contribute to insulin resistance, a risk factor for preeclampsia. In many
studies, decrease in serum magne- sium levels has been considered as the cause of patho- genesis of
preeclampsia. Minerals have an important
 influence on the health of pregnant women and growing fetus. Among them, serum or placental zinc (Zn)
concen- trations have been reported to be low in PE women. Fur- thermore, decreased levels of zinc, selenium,
and copper have been observed in patients with preeclampsia [3]. In another side, the nutrients with antioxidants
among high risk women showed a protective effect [4]. Folic acid has been hypothesized as a protective agent of
preeclampsia.
 Maternal obesity and insulin resistance are also believed to be important risk factors for the development of pla-
cental endothelial dysfunction and preeclampsia. Preven- tion of preeclampsia has remained elusive, owing
largely to their complex nature. Currently, maternal obesity in prepregnancy is one of the strongest modifiable
risk fac- tors. Recent studies have shown a relation between obesity in prepregnancy and the risk of
preeclampsia. The reason for obesity being associated with an increased risk of preeclampsia was explained by
increased levels of serum triglycerides and very low-density lipoprotein particles in obese women. This lipid
alterations have been suggested to promote oxidative stress caused by ischemia–reperfusion mechanism or
activated neutrophils, which leads to endothelial cell dysfunction [1].
 The hypothesis about nutritional status and body mass index (BMI) prepregnancy associated with preeclampsia
has intrigued us to study the risk factor for preeclampsia in Dr. M. Djamil Hospital, Padang, Indonesia.
 Methods
 This was a case–control study at the Department of Obstetric and Gynecology in Dr. M. Djamil Hospital,
Padang, Indonesia, between January and December 2013. Pregnant women after 20 weeks gestations were
included. A total of 140 patients were enrolled in this study with 70 cases and 70 controls. Cases were those
diagnosed with preeclampsia; meanwhile, controls were normotensive pregnant women without any other
comorbidity.
 After providing written informed consent, all subjects completed an interview for their nutritional status and
prepregnancy BMI after delivery. The nutritional status was assessed by Food Frequency Questionnaire (FFQ)
and then analyzed by Nutrisurvey Program. Calories, protein, fat, carbohydrates, calcium, phosphorus, zinc,
sodium, potassium, magnesium, vitamin A, folic acid, vitamin B1, vitamin B2, niacin, vitamin B6, vitamin B12,
vitamin C, and vitamin E were assessed. Maternal BMI was catego- rized into two groups: normal BMI and
abnormal BMI. Normal BMI was defined as 18.5–24.9 kg/m2. The inde- pendent samples t test was used for
nutritional status, and
 Chi-square test was used for BMI. Odds ratio (OR) with
 95% CI was calculated. A p value \0.05 was considered
 statistically significant. For the nutrition variable, if the p value \0.25 then continued by logistic regression back-
ward to assess the risk factor.
 Results
 Most of the subjects had normal weight, both in case and control groups. Table 1 shows that prevalence of
abnormal BMI was more common in the preeclampsia group com- pared with those without preeclampsia 19
(27.1%) versus
 12 (17.1%). BMI was not found as a significant risk factor in this study (p = 0.222).
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As shown in Table 2, the mean level for most of the
 variables, except calories, fat, and vitamin B1, was lower in subjects with preeclampsia than those without
preeclamp- sia. The difference for most of the subjects was also sta- tistically significant with p \ 0.05, except for
vitamin B1 and vitamin B2. Table 3 shows the risk factors for preeclampsia obtained by logistic regression
analyses. The nutrients that were significantly associated with increased risk of preeclampsia were deficiency of
vitamin E, zinc, fat, calcium, and vitamin C. Excess of calories and carbohy- drate also significantly associated
with increased risk of preeclampsia. Meanwhile, vitamin A and vitamin B1 were protective factors.
 Discussion
 The reason for obesity being associated with an increased risk of preeclampsia was explained by increased levels
of serum triglycerides, very low-density lipoproteins, and formation of small low-density lipoprotein particles in
obese women. This lipid profile was also found in women with preeclampsia. These lipid alterations have been
suggested to promote oxidative stress, caused by ische- mia–reperfusion mechanism or activated neutrophils,
which leads to endothelial cell dysfunction [1]. Moreover, dyslipidemia also can cause atherothrombosis and
induce the aggregation of the thrombocytes than can lead to coagulopathy which is a characteristic of
preeclampsia.
 Obesity is accompanied by oxidative stress. The origin of oxidative stress is proposed to be secondary to
increased free fatty acids and inflammation. It is also suggested that diet can contribute to oxidative stress.
Obese individuals have lower blood concentrations of antioxidants. This could be due to reduced dietary intake
of antioxidants, but increased consumption by reactive oxygen species is also possible [5].
 In this study, we found no relationship between BMI with preeclampsia. As mentioned before, dyslipidemia is
the important factor that can lead into preeclampsia. But our study did not assess profile lipid of the subjects.
Fur- thermore, central obesity has a higher risk of preeclampsia. Central obesity is characterized by visceral fat.
Visceral fat produces C-reactive protein (CRP), PAI-1, and leptin that contributes to oxidative stress. People with
central obesity have a higher risk to get preeclampsia. In this study, we did not assess the central obesity of the
subjects. Measures of body composition, including percent body fat, may very likely identify the obese woman
at risk of preeclampsia more accurately.
 Our study found that carbohydrate intake in preeclampsia group was significantly higher than the non-
preeclampsia group. The subjects that have higher carbo- hydrate will have lower protein level. Meanwhile,
protein is needed in the process of trophoblast invasion so the protein-energy malnutrition increases the risk of
preeclampsia. We also found that intake of proteins in preeclampsia was significantly lower in the preeclampsia
group.
 Folic acid and vitamin B12 are also a protector factors against preeclampsia. Those micronutrients play an
important role in suppressing the metabolism of homo- cysteine, whereas the excess of homocysteine was a cau-
sative factor of endothelial damage and became one of the causes of preeclampsia. In addition, folic acid-
supple- ments preconception enhance the placentation process and can prevent preeclampsia. Three earlier
cohort studies assessed the effect of folic acid containing multivitamins (including folic acid) and gestational
hypertension (in- cluding preeclampsia), and all showed a protective effect of folic acid supplementation on
preeclampsia [2, 6, 7].
 Table 1 Asssociation between body mass index and the risk of preeclampsia
 BMI
 Preeclampsia
 %
 Non-preeclampsia
 %
 p*
 OR
 CI 95%
 Min.
 Max.
 Abnormal BMI
 19
 27.1
 12
 17.1
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0.222
 1.801
 0.797
 4.067
 Normal BMI
 51
 72.9
 58
 82.9
 70
 100
 70
 100
 BMI body mass index, OR odds ratio, CI confidence interval
 * p value were obtained by Chi-square
 Table 2 Differences of mean nutritions level in preeclampsia and non-preeclampsia group
 Preeclampsia
 Mean (95% CI)
 Non-preeclampsia
 Mean (95% CI)
 p*
 Calorie (Kcal)
 1269.22 (745.2–2214)
 1171.15 (649.1–2447.6)
 0.048
 Protein (g)
 42.37 (23.03–95.42)
 54.9 (24.2–200.6)
 0.000
 Fat (g)
 26.8 (4.65–58.9)
 32.4 (10.79–93.12)
 0.009
 KH (g)*
 219.5 ± 56.8
 163.49 ± 46.5
 0.000
 Calcium (mg)
 234.7 (63.7–758.3)
 9362.9 (63.7–922.4)
 0.000
 Phosphor (mg)
 589.4 (296.5–1444.5)
 714.6 (324.6–2353.4)
 0.006
 Fe (mg)
 9.4 (2.84–23.9)
 11.06 (2.84–35.6)
 0.005
 Zinc (mg)
 4.8 (2.39–12.87)
 5.5 (2.4–16.5)
 0.005
 Natrium (mg)
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299.3 (76.9–970.24)
 533.3 (105.9–1847.60)
 0.000
 Kalium (mg)*
 595.4 ± 237.2
 732.15 ± 367.8
 0.010
 Magnesium (mg)
 181.1 (97.1–370.14)
 210.0 (97.1–554.5)
 0.010
 Vitamin A (lg)
 544.9 (174.9–1567.4)
 763.9 (174.9–3354.5)
 0.000
 Folic acid (lg)
 108.6 (56.8–421.6)
 163.5 (56.83–497.9)
 0.000
 Vitamin B1 (mg)
 0.7 (0.27–2.15)
 0.65 (0.27–2.01)
 0.085
 Vitamin B2 (mg)
 0.94 (0.25–2.45)
 1.1 (0.25–2.7)
 0.046
 Niacin (mg)
 4.3 (0.6–11.9)
 5.8 (2.1–23.7)
 0.000
 Vitamin B6 (mg)
 1.1 (0.66–2.14)
 1.22 (0.67–3.8)
 0.009
 Vitamin B12 (mg)
 1.1 (0.15–9.15)
 2.8 (0.27–21.1)
 0.000
 Vitamin C (mg)
 43.4 (8.4–136.8)
 68.2 (19.2–262.7)
 0.000
 Vitamin E (mg TE)
 1.9 (0.2–4.4)
 3.6 (1.8–8.2)
 0.000
 CI confidence interval
 * p value was obtained by independent samples t test
 A recent large cohort study from Denmark also showed that regular use of folic acid in pregnancy was related to
a reduced risk of preeclampsia among normal-weight women [8]. But in this study, we did not found the folic
acid and vitamin B12 as a protective agent of preeclampsia. The different result maybe caused by
supplementation that has been done generally. In other side, the no supplementation subject was rare so that
selection bias/confounding become difficult to control.
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The previous study showed that vitamin B6 deficiency is associated with cardiovascular disease. This is related
to the function of B6 for the establishment of pyridoxal 5 phosphate which is an essential coenzyme in many
meta- bolism processes. The coenzyme deficiency will lead to the diseases such as preeclampsia. Another
micronutrients that play a role in the occurrence of preeclampsia is magne- sium. In a study, obtained serum
magnesium levels in patients with preeclampsia were significantly lower than normal pregnancy. This indicates
that magnesium as one of the predictors of preeclampsia. Magnesium also allegedly acted as a coenzyme
intracellular and functions to maintain contraction and vascular tone [2].
 Serum zinc, calcium, and magnesium levels have been compared between preeclamptic and healthy pregnant
women in various studies. Some results showed that copper, zinc, and
 calcium levels were significantly lower in preeclamptic patient, whereas magnesium concentrations showed no
sig- nificant differences between the two groups [9]. Our study is consistent with that study, whereas we found
zinc and calcium deficiency as a risk factor for preeclampsia (OR 99.46, 95% CI
 1.37, 7219; OR 31, 95% CI 1.21, 841).
 Our study found that vitamin E and A deficiency increase the risk of preeclampsia (OR 19.57, 95% CI
 2.5, 151, OR 1768, 95% CI 10.22, 305,890). Antioxi-
 dants are important in maintaining cellular integrity in a normal pregnancy by inhibiting peroxidation reaction
and thus protecting enzymes, proteins, and cells from destruction by peroxides. Antioxidant defense mecha-
nisms include cellular and extracellular enzymes such as free radical scavengers, including vitamin C and E, and
metabolites such as bilirubin and uric acid. Vitamin C and E are antioxidants derived from the diet. Vitamin C
scavenges free radicals in the aqueous phase, and the lipid-soluble vitamin E acts in vivo to prevent the for-
mation of lipid peroxides and thus protect cell mem- branes. There is evidence of oxidative stress in women with
established preeclampsia, including increased plasma concentration of 8-epi-prostaglandin F2a, lipid peroxides,
and decreased concentrations of antioxidants such as vitamins C and E [10].
 Table 3 Results of multivariate logistic regression analysis
 OR p 95% confidence interval
 Calorie
 3.87
 0.028
 2.39 ± 6,268,293
 Protein
 0.049
 0.650
 0.27 ± 12,994
 Fat
 59.182
 0.138
 3.14 ± 500
 KH
 52.9
 0.063
 0.801 ± 3495
 Calcium
 109
 0.119
 0.29 ± 40,041
 Fe
 9.84
 0.149
 0.441 ± 219
 Zinc
 99.4
 0.035
 1.37 ± 7219
 Natrium
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0.62
 0.731
 0.041 ± 9.37
 Kalium
 0.005
 0.054
 0.000 ± 1.08
 Magnesium
 0.015
 0.528
 0.000 ± 7321
 Vitamin A
 0.002
 0.055
 0.000 ± 1.14
 Folic acid
 42.9
 0.193
 0.15 ± 12,383
 Vitamin B1
 0.000
 0.009
 0.000 ± 0.014
 Vitamin B2
 3.75
 0.550
 0.049 ± 285
 Niacin
 2.39
 0.068
 0.571 ± 1E ? 007
 Vitamin B6
 0.299
 0.591
 0.004 ± 24.3
 Vitamin B12
 4.511
 0.243
 0.36 ± 56.4
 Vitamin C
 19.5
 0.004
 2.52 ± 151
 Vitamin E
 1.76
 0.004
 10.2 ± 30.5
 OR odds ratio
 Conclusions
 Deficiency of vitamin E, zinc, fat, calcium, and vitamin C, and excess of calories and carbohydrate were
associated with increased risk of preeclampsia.
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Differences in Malondialdehyde and Catalase Activity Levels
 Between Abortion and Normal Pregnancy
 INTRODUCTION
 Abortion is defined as a termination of a pregnancy before
 20 weeks of gestation or when the fetal weight is less than
 500 g. Clinically, the most frequent abortion encountered in the hospital is incomplete abortion. Patients usually
come with bleeding and severe abdominal pain. The second one is threatened abortion. Threatened abortion is
the most common complication in the first half of pregnancy and have incidence about 20-25%. Less than 30%
of the women who experience threatened abortion will end in spontaneous abortion1.
 There are many factors that associated with abortion, so it is hard to determine the exact mechanism. In spite of
many possibilities, there is now a clear evidence that abortion is associated with placental oxidative stress. The
abnormal placentation will lead to placental oxidative stress with resultant destructive effects on the
syncytiotrophoblast. The theory has been proposed as a mechanism involved in the etiopathogenesis of
abortion2.
 The body has many antioxidant systems to defend the excessive Reactive Oxygen Species (ROS) production3.
In a healthy body, ROS and antioxidant remain in balance. When the body has an excessive amount of ROS,
Oxidative Stress (OS) then occurs. An increase in the expression of oxidative stress marker in the trophoblast
was detected in abortion and this was speculated to be a cause of early pregnancy loss4.
 Antioxidant system divided into enzymatic and nonenzymatic group. Catalase (CAT) is one of enzymatic
antioxidant that can remove hydrogen peroxide (H2O2), prevents lipid peroxidation in the cell membrane and
works as free radicals binding5. The CAT role in pregnancy is very important, in early pregnancy CAT plays a
role for implantation by protecting the blastocysts from superoxide radicals in the endometrium. The CAT is also
important for embryonic development and the maintenance of early pregnancy. The CAT level was found
increased during pregnancy and low CAT activity in plasma or placenta found in cases of spontaneous abortion6.
Another study also suggests that low antioxidant level increases the risk of spontaneous abortion7.
 Free radicals are thus highly unstable molecules that have electrons available to react with a various organic
substrate such as lipids, proteins and DNA8. Accumulation of lipid peroxides may cause not only tissue damage
but also some biological events to accelerate the termination of pregnancy. It has been reported that ROS or lipid
peroxide stimulate synthesis of PGF2α that causes uterine contraction6. Oxidative stress has been variably
determined by many ways. The most reliable assessment of free radicals synthesis is using assays directly to
detect the superoxide or other free radical. However, this technique is difficult and require specialized document.
In another side, measurement of the products of oxidative modification product provides the most direct and
possible assessment of oxidative stress. Malondialdehyde
 (MDA) is a metabolite of lipid peroxides that detectable in plasma and was used as an indicator of lipid
peroxidation9. This study was carried out to estimate the mean difference of CAT and MDA in normal
pregnancy, threatened abortion and incomplete abortion.
 MATERIALS AND METHODS
 This was an observational study with cross-sectional design on February-December, 2014. The population was
all pregnant women before 20 weeks gestations were enrolled in the maternity ward of Dr. M. Djamil Hospital
and Dr. Reksodiwiryo Hospital, Padang, Indonesia. Subjects were taken by consecutive sampling method. Cases
were those diagnosed with threatened and incomplete abortion by a specialist doctor. Meanwhile, controls were
normal pregnant women without any other comorbid.
 Exclusion criteria were a mother with hydatidiform mole, uterus disorder, myoma, history of provocating and
recurrent abortion. After providing informed, written consent, subject’s blood was taken from antecubital vein
for analyzed the CAT activity and MDA concentration with spectrophotometry method in Biomedical
Laboratory of Medical Faculty of Andalas University.
 The significant difference among the three groups was analyzed with ANOVA test. If p<0.05 was found, then
the analysis continued with post hoc multiple comparison test to determined the differences between two group.
Statistical analysis was conducted using a computer program.
 RESULTS
 During the study period, 42 blood samples were collected, consisting of 14 subjects with threatened abortion,
 14 subjects with incomplete abortion and 14 subjects with normal pregnancy before 20 weeks gestations. Table 1
shows the activity of CAT enzyme in incomplete abortion group was
 51.10±12.20 IU mgG1, the threatened abortion group was
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66.46±9.11 IU mgG1, whereas normal pregnancy group was
 78.26±8.88 IU mgG1. The analysis with statistical tests ANOVA found that p<0.001. To saw the specific
difference between two subjects, the analysis continued by post hoc multiple comparisons test. As presented in
Table 2, there were significant differences of CAT activity between incomplete abortion group and threatened
abortion (p<0.001), incomplete abortion and normal pregnancy (p<0.001), threatened abortion and normal
pregnancy (p = 0.01).
 Table 1: Difference of catalase activity in incomplete abortion, threatened
 abortion and normal pregnancy Catalase activity
 Parameters Mean±SD (IU mgG1) 95% CI p-value*
 Incomplete abortion 51.10±12.20 44.06-58.15 <0.001
 Threatened abortion 66.46±9.11 61.20-71.72
 Normal pregnancy 78.26±8.88 73.13-83.38
 *p-values are obtained by ANOVA test, SD: Standard deviation, CI: Confidence interval
 Table 2: Post hoc test for the difference of the mean level of catalase activity
 in incomplete abortion, threatened abortion and normal pregnancy Incomplete Threatened Normal
 Parameters abortion abortion pregnancy
 Incomplete abortion - <0.001* <0.001* Threatened abortion <0.001* - 0.01* Normal pregnancy <0.001* 0.01* -
 *p-value obtained by Tukey’s test to determine the difference between two groups
 Table 3: Difference of malondialdehyde level in incomplete abortion,
 threatened abortion and normal pregnancy Malondialdehyde level
 Parameters Mean±SD (nmol mLG1) 95% CI p-value*
 Incomplete abortion 4.02±0.36 3.81-4.23 <0.001
 Threatened abortion 3.46±0.39 3.24-3.68
 Normal pregnancy 2.83±0.21 2.71-2.96
 *p-values are obtained by ANOVA test, SD: Standard deviation, CI: Confidence interval
 Table 4: Post hoc Test for the difference of the mean level of malondialdehyde in incomplete abortion,
threatened abortion and
 normal pregnancy Incomplete Threatened Normal
 Parameters abortion abortion pregnancy
 Incomplete abortion - <0.001* <0.001* Threatened abortion <0.001* - <0.001* Normal pregnancy <0.001*
<0.001* -
 *p-value obtained by Tukey’s test to determine the difference between two groups
 As presented in Table 3, the mean level of MDA in incomplete abortion group was 4.02±0.36 nmol mLG1, the
threatened abortion group was 3.46±0.39 nmol mLG1, whereas in normal pregnancy group was 2.83±0.21 nmol
mLG1 with p = 0.00 by ANOVA test. To saw the difference between two group analysis continued with post hoc
test. According to the Table 4, it was found that there were significant differences of MDA level between
incomplete abortion with threatened abortion (p<0.001), incomplete abortion and normal pregnancy group
(p<0.001), threatened abortion and normal pregnancy (p<0.001).
 DISCUSSION
 In this study, it was found that the mean of MDA level of incomplete abortion was higher than threatened
abortion and normal pregnancy (p<0.05). Meanwhile, the mean level of CAT activity was lower in incomplete
abortion than threatened abortion and normal pregnancy (p<0.05).
 This study was accordance with a study conducted by Abdul-Barry et al.8 that found the serum MDA level was
significantly higher in patients with a history of recurrent spontaneous abortion than women with a healthy
pregnancy. Ozkaya et al.10 also reported that the spontaneous abortion before 8 weeks gestation was associated
with higher serum of MDA than healthy pregnancy (66.4±13.7 vs. 40.3±16.1, p<0.01). Because MDA is a side
product of lipid peroxidation, the increase in MDA level may reflect an overproduction of lipid peroxides and
alter antioxidant defend mechanism.
 Jauniaux et al.11 suggested the theory of how the free radical is higher in abortion than in normal pregnancy.
They found that the intervillous O2 flow appeared much earlier in the abortion group so it can lead to excessive
free radicals production that can cause abortion11.
 The oxidative stress during pregnancy occurs in response to the fetoplacental energy demand. How the oxidative
stress cause an abortion have been studied by other study. Many mechanisms have been proposed as the theory.
Zhu et al.12, suggested three factors that has an impact on the pathogenesis of abortion. First, the ROS can cause
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the lipid peroxidation injury in the embryo. Second, the increasing free radicals can change oxygen partial
pressure in embryonic cells. And the last, increased of free radicals can lead to ischemia-reperfusion injury in the
fetus12.
 Actually, increased of antioxidants activity also found in early healthy pregnancy. These indicate that the
oxidative stress actually also occurs in normal pregnancy but the sufficient antioxidants are defended the free
radicals and prevented the damage6,13,14. In this study, the mean activity of CAT enzyme of incomplete
abortion was lower than normal pregnancy and threatened abortion (p<0.05). It means that there were
differences between the CAT enzyme activity in incomplete abortion, threatened abortion and normal pregnancy.
It was suggested that the excess of free radicals and the decreased of antioxidants in this study were associated
with the abortion.
 Sugino et al.6 found that CAT total activity was decrease
 and prostaglandin F2α synthesis was increase in decidua in cases of spontaneous abortion with vaginal bleeding.
They proposed that the termination of pregnancy was caused by decreasing activity of CAT which stimulates the
synthesis of prostaglandins6. This study was accordance with the study by Yigenoglu et al.15 that found the total
antioxidant capacity is lower in pregnant women with history of spontaneous abortion than healthy pregnant
women. It also accordance with a study conducted by Biri et al.16 that found the CAT activity was higher in
abortion group than in control group (87.62±8.19 vs
 44.47±3.79 IU mgG1).
 CONCLUSION
 Abortion group had lower antioxidant concentration and higher free radicals than normal pregnancy. There was
an imbalance of free radical and antioxidant concentration in abortion.
 SIGNIFICANT STATEMENT
 The imbalance of free radical and antioxidant has been proposed to one of many theories that can cause abortion.
This study tried to determine the comparison of antioxidant and free radical level by analyzed the catalase
activity and malondialdehyde concentration in normal pregnancy and
 abortion. Malondialdehyde (MDA) is a metabolite of lipid peroxides that used as an indicator of lipid
peroxidation as a free radical. Meanwhile, catalase is one of antioxidant that works as free radicals binding by
preventing lipid peroxidation in the cell membrane. The result of this study will determine the imbalance of free
radicals and antioxidants in abortion and will help the medical field to develop the prevention of abortion.
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Research Article
 Differences in Mean Levels of Maternal Resistin Serum between Early Onset Preeclampsia (EOPE) and Late
Onset Preeclampsia (LOPE)
 Research Article
 Differences in Mean Levels of Maternal Resistin Serum between
 Early Onset Preeclampsia (EOPE) and Late Onset Preeclampsia
 (LOPE)
 INTRODUCTION
 Preeclampsia is one of the major causes of morbidity
 and mortality of the mother and fetus. World Health
 Organization (WHO) reported the number of deaths caused by
 preeclampsia by 16% in developing countries
 . Preeclampsia
 resulting 3-25 fold increased risk obstetric complications
 and is the cause of 30-40% of perinatal deaths in Indonesia
 1
 .
 The incidence of preeclampsia ranges between 5-10%
 of all pregnancies
 . Incidence of preeclampsia in the United
 States, Canada and Western Europe ranges between 2-5%
 of all pregnancies and higher, 4-18% in some developing
 countries in Africa
 1
 . The incidence of preeclampsia in
 Indonesia ranged between 3-10%
 3
 .
 In Dr.M. Djamil General Hospital in Padang during the
 2
 year 2011, the incidence of preeclampsia was 8.31%, on 2012
 was 11.47% and on 2013 was 12.02%.
 Preeclampsia is divided into early onset preeclampsia
 (EOPE) (<34 weeks) and late onset preeclampsia (LOPE)
 (>34 weeks) of pregnancy based on the onset of clinical
 manifestations of preeclampsia. The EOPE and LOPE has a
 different pathogenesis. The PEAD is often associated with
 impaired uteroplacental perfusion caused by disruption of
 trophoblast invasion, while LOPE is often associated with the
 presence of extrinsic and maternal factors
 .
 Preeclampsia is a protean syndrome, in which multiple
 4,5
 organ systems can be affected compared to the others.
 Preeclampsia is mainly characterized by hypertension and
 proteinuria or may be associated with abnormalities in
 laboratory test results that renal function, hepatic or
 hemostasis after 20 weeks of pregnancy
 .
 Analysis of risk factor for preeclampsia is needed to
 1,6
 mitigate the adverse effects of preeclampsia. One among
 of these risk factor is resistin which is associated with
 inflammation and insulin resistance, so that resistin was a
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maternal risk factor that associated with LOPE
 .
 Resistin is an adipose tissue-specific secretory factor
 7
 (ADSF), a hormone secreted by adipose tissue that induces
 insulin resistance in muscle and liver. Resistin stimulated by
 inflammatory conditions that produce proinflammatory
 cytokines
 .
 Preeclampsia is associated with inflammation and insulin
 7,8
 resistance which is affected by resistin. Resistin is associated
 with late onset preeclampsia because it was a maternal
 factors, so there was an increasing of maternal resistin serum
 levels in late onset preeclampsia
 .
 Previous study reported an elevated of maternal resistin
 7,8
 serum levels associated with a systemic inflammatory
 response and insulin resistance which is both of them are
 2
 2
 increased in preeclampsia compared to normal pregnancy
 .
 The other study showed the mean of Homeostasis Model
 Assessment-Insulin Resistance (HOMA-IR) and high sensitivity
 C-reactive protein (hs-CRP) was higher in late onset
 preeclampsia than early onset preeclampsia group.
 From
 various studies on the above it could be estimated that the
 inflammatory factor and insulin resistance are associated
 with higher levels of resistin more dominant in late onset
 preeclampsia group compared to early onset preeclampsia
 group.
 The HOMA-IR could be used as an indicator of insulin
 resistance, but not for inflammatory states, contrary hs-CRP
 could be used as an indicator of inflammation, but not for
 insulin resistance. Resistin is expected to describe both of
 them, because it was associated with insulin resistance and
 inflammation
 7
 .
 MATERIALS AND METHODS
 This study is an analytical cross sectional study with
 2 0 w o me n o f e a r l y o n s e t p r e e c l a mp s i a ( E OP E ) a n d 2 0 w o me n
 of late onset preeclampsia (LOPE) who met the inclusion
 criteria and there were no exclusion criteria. The samples
 were recruited in Dr.M. Djamil General Hospital, Padang from
 July-October, 2015.
 The inclusions criteria were women who detected early
 onset preeclampsia or late onset preeclampsia in obstetrics
 emergency ward of Dr.M. Djamil General Hospital, Padang
 and willing to follow the research for taking blood samples.
 The exclusions criteria were diabetes mellitus (random blood
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sugar as >200 mg dLG
 ), had suffered coronary heart disease,
 chronic kidney disease, chronic liver disease and obesity
 (BMI before pregnancy >25 kg mG
 1
 ).
 Maternal resistin serum was examined by enzyme-linked
 2
 immunosorbent assay (ELISA) method in Biomedic Laboratory
 in Medical Faculty of Andalas University. Statistical analysis
 was conducted by using SPSS program 20th version. The data
 distribution was normal with p>0.05. The differences mean
 levels of maternal resistin serum was analyzed by using
 independent t-test.
 RESULTS
 Characteristics of research subjects: Forty patients of
 research subjects consisted 20 patients of early onset
 preeclampsia (EOPE) and 20 patients of late onset
 preeclampsia (LOPE). Mean levels of maternal age in EOPE
 group is 34.4±5.144 years, whereas in LOPE group is
 32.9±6.324 years with p = 0.416. According to maternal age
 9-12
 Table 1: Characteristics of research subjects between early onset preeclampsia and late onset preeclampsia
 Characteristics EOPE (n = 20) LOPE (n = 20) Total (%) p
 Maternal age group
 <20 years 0 (0%) 0 (0%) 0
 20-35 years 8 (40%) 10 (50%) 45 0.537
 >35 years 12 (60%) 10 (50%) 55
 Maternal age (0±SD) years 34.4±5.144 31.9±6.314 0.416
 Gravidity group
 Primigravid 6 (30%) 7 (35%) 32.5 0.744
 Miltigravid 14 (70%) 13 (65%) 67.5
 Gravidity (0±SD) 2.4±1.314 2.65±1.461 0.573
 BMI group
 Underweight 0 (0%) 0 (0%) 0
 Normoweight 14 (70%) 12 (60%) 65 0.520
 Overweight 6 (30%) 8 (40%) 35
 BMI (0±SD) 22.55±1.595 22.59±1.812 0.946
 Table 2: Mean levels of maternal resistin serum in early onset preeclampsia and
 late onset preeclampsia
 EOPE LOPE
 ---------------------- -----------------------Variable
 Mean SD Mean SD
 Maternal resistin serum (ng mLG
 1
 ) 2.526 1.603 8.891 6.219
 Table 3: Mean levels difference of maternal resistin serum in early onset
 preeclampsia and late onset preeclampsia
 Variable Mean difference CI (95%) p
 Maternal resistin serum (ng mLG
 1
 ) 6.365 3.3835-9.3475 0.000
 groups, study of subjects in early onset preeclampsia
 consists 8 patients (40%) in group of maternal age
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20-35 years old, 12 patients (60%) in group of maternal age
 >35 years old, none in group of maternal age <20 years old.
 Research subjects of late onset preeclampsia consists of 1 0
 patients (50%) in group of maternal age 20-35 years old, 10
 patients (50%) in group of maternal age >35 years old, none
 in group of maternal age <20 years old.
 Mean levels of gravidity in early onset preeclampsia
 (EOPE) group is 2.4±1.314, whereas in late onset
 preeclampsia (LOPE) group is 2.65±1.461 with p = 0.573.
 According to gravidity groups, study of subjects in early
 onset preeclampsia consists 6 patients (30%) in group of
 primigravida, 14 patients (70%) in group of multigravida.
 Research subjects of l ate onset preecl ampsi a c onsi sts of
 7 patients (35%) in group of primigravida, 13 patients (65%).
 Mean levels of Body Mass Index (BMI) in early onset
 preeclampsia (EOPE) group is 22.551±1.595, whereas in late
 onset preeclampsia (LOPE) group is 22.588±1.4812 kg mG
 with p = 0.946. According to BMI groups, study of subjects in
 EOPE consists 14 patients (70%) in group of normal
 weight, 6 patients (30%) in group of overweight, none in
 group BMI underweight. Research subjects of late onset
 preeclampsia consists 12 patients (60%) in group of normal
 weight, 8 patients (40%) in group of overweight, none in
 group BMI underweight.
 2
 3
 There were no statistically significant differences
 regarding maternal age, group of maternal age, gravidity,
 group of gravidity, BMI and group of BMI characteristic
 between those two groups with p>0.05 showed in Table 1.
 Mean levels of maternal resistin serum in early onset
 preeclampsia and late onset preeclampsia: Mean levels of
 maternal resistin serum was higher in late onset preeclampsia
 vs
 2.526±1.603 ng dLG
 than early onset preeclampsia (8.891±6.219 ng mLG
 1
 ), showed in Table 2.
 Differences in mean levels of maternal resistin serum
 between late onset preeclampsia and early onset
 preeclampsia: The data distribution was normal with
 Kolmogorov Smirnov test. Analysis was performed with
 independent t-test. Table 3 showed the differences in mean
 levels of maternal resistin serum between early onset
 preeclampsia and late onset preeclampsia as 6.365 ng mLG
 with Confidence Interval (CI) 95% 3.384-9.347. There is a high
 significant differences with p<0.001.
 DISCUSSION
 The mean levels of maternal serum resistin in early
 onset preeclampsia (EOPE) group was 2.526±1.603 ng mLG
 whereas in late onset preeclampsia (LOPE) group was
 8.891±6.219 ng mLG
 (Table 2), with a mean difference
 6.365 ng dLG
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1
 1
 , 95% CI 3.384-9.347. Statistical test showed
 p<0.001, that the mean levels of maternal serum resistin
 significantly was higher in LOPE than EOPE (Table 3).
 Resistin is a hormone secreted from adipose tissue that
 induces insulin resistance in muscle and liver. Resistin
 stimulated by inflammatory conditions that produce
 proinflammatory cytokines. Resistin contribute to the
 inflammatory disorders such as coronary heart disease,
 1
 1
 1
 chronic kidney disease and liver cirrhosis as well as insulin
 resistance in diabetes mellitus through the activation of
 proinflammatory cytokines varied which depending on the
 organs affected
 .
 Insulin resistance and inflammation were the condition
 7,8
 associated to preeclampsia. This factor related to the role of
 resistin through the release of proinflammatory cytokines.
 The relationship between resistin and preeclampsia is
 connected by those which is a maternal factor in
 preeclampsia. Therefore, resistin is associated to late onset
 preeclampsia, so the levels of maternal resistin serum was
 increased in late onset preeclampsia
 .
 Inflammation and insulin resistance have been
 7,8
 investigated, that the comparasion between HOMA-IR and
 hs-CRP in EOPE and LOPE. This study reported the results
 that mean levels of HOMA-IR and hs-CRP were higher in
 LOPE compared to EOPE (HOMA IR: 4.86±5.50 vs 3.99±5.97
 and hsCRP: 123.08±38.67 vs 26.54±34.7 mg LG
 ). This study
 suggested that the inflammatory factor and insulin resistance
 were more dominant in LOPE compared to EOPE.
 1
 A s i mi l ar r es ul t s w as r epor t ed i n whi c h t he mean l evel s
 of maternal resistin serum was higher in preeclampsia
 compared to normal pregnancy related to an increase in
 insulin resistance and the response systemic inflammation
 that happened in preeclampsia particularly late onset
 preeclampsia
 .
 A cross sectional study in which two groups of pregnant
 9-12
 women with preeclampsia (n = 15) and normal pregnancy
 (n = 23) demonstrated th mean levels of maternal resistin
 serum was higher in preeclampsia (5.68±0.41 ng mLG
 )
 compared to normal pregnancy (4. 65±0. 32 ng mLG
 ),
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p = 0.028. The mean levels of maternal resistin serum related
 to the mean of HOMA-IR and proinflammatory cytokines
 that were elevated in preeclampsia compared to normal
 pregnancy. T he mean of H OMA-I R ( 2. 5±0. 8 vs 1. 4±0. 1),
 IL-6 (6.34±1.02 vs 2.80±0.31) and TNF-" (1.89±0.18 vs
 1.23±0.10)
 .
 Another cross-sectional study on two groups of
 9
 pregnant women, which were preeclampsia (n = 29) and
 normal pregnancy (n = 30), found that mean levels of
 maternal resistin serum was higher in preeclampsia
 61.98±32.26 ng dLG
 , compared to normal pregnancy
 38.06±31.26 ng dLG
 1
 1
 , p = 0.013. Insulin resistance is thought
 related the increasing the levels of maternal resistin serum,
 because the mean of HOMA-IR was higher in preeclampsia
 compared to normal pregnancy (4:44±4:02 vs 3.99±2.82)
 .
 A cross sectional study was conducted on two groups of
 pregnant women, which are preeclampsia (n = 50) and normal
 pregnancy (n = 50). The median levels of maternal resistin
 1
 1
 10
 4
 serum were higher in preeclampsia 61 ng mLG
 compared to
 normal pregnancy 25.5 ng mLG
 1
 1
 , p = 0.033. Insulin resistance
 is thought related the increasing the levels of maternal
 resistin serum, because the median of HOMA-IR was higher in
 preeclampsia compared to normal pregnancy (4.7 vs 3.6)
 .
 A cross sectional study was conducted on two groups of
 pregnant women, which are preeclampsia (n = 16) and normal
 pregnancy (n = 22). The mean levels of maternal resistin
 serum was higher in preeclampsia (12.06±0.973 ng mLG
 )
 compared t o n ormal p regnancy ( 7. 35±1. 195 ng mLG
 ),
 p = 0.041. Inflammatory factors is thought related the
 increasing the levels of maternal resistin serum in
 preeclampsia. There was an increasing mean levels of
 TNF" in preeclampsia compared to normal pregnancy
 (15.23±0.674 vs 12.84±0.348 ng mLG
 1
 , p = 0.021)
 . Based on
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that description, there was a correlation between previous
 studies and this study
 9-12
 12
 .
 The mean levels of HOMA-IR and hs-CRP were higher in
 late onset preeclampsia than early onset preeclampsia, so
 according to those studies above, the insulin resistance and
 inflammation that were higher in late onset preeclampsia than
 early onset preeclampsia related to the levels of maternal
 resistin serum that was higher in late onset preeclampsia than
 early onset preeclampsia. It was appropriate with the results
 of this research that the mean levels of maternal resistin
 serum in late onset preeclampsia was significantly higher than
 early onset preeclampsia with p<0.001.
 CONCLUSION
 The mean levels of maternal resistin serum was higher
 significantly in late onset preeclampsia (LOPE) compared to
 early onset preeclampsia (EOPE).
 11
 1
 1
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Differences in brain-derived neurotrophic factor between neonates born to mothers with normal and low ferritin
 INTRODUCTION
 Nutrition plays a role in the intellectual development of a child during intrauterine life. The most common nutri-
tional deficiency found in pregnant women is iron defi- ciency.1,2 Pregnancy is a condition that increases the
iron requirement to meet fetal and placental needs. Insuffi- cient iron stores before pregnancy and inadequate
iron intake during pregnancy can lead to iron deficiency ane- mia.3 The iron deficiency can be examined by
assessing the serum ferritin that directly correlates with the total amount of iron stored in the body. Iron
deficiency anemia is usually found when the serum ferritin is less than 12 μg/dL.4,5
 A study by Milman et al (1991) suggested that neonates born to mothers receiving iron supplementation during
pregnancy had higher serum ferritin than neonates born to mothers receiving placebo.6 Consistent with the
previous study, Gaspar et al (1993) and Perez et al (2005) reported that neonates born to mothers with low serum
ferritin tend to have low serum ferritin as well.7,8 Shao et al (2012) also found that there was a positive
correlation between maternal serum ferritin and iron reserve in term neonates.9
 Iron deficiency is associated with decreased intellectual or cognitive function. The brain region that serves as a
 center of memory, learning, and behavior is the hippo- campus. Iron is essential for the hippocampus to under-
take dendritogenesis, synaptogenesis, neurogenesis, and synthesis of neurotrophic factors that facilitate brain
growth and development commencing in intrauterine life. The main neurotrophic factor in the hippocampus for
learning, memory, and behavior is brain-derived neu- rotrophic factor (BDNF). BDNF is a family of neurotro-
phins that plays an important role in neuronal cell plas- ticity, oligodendrocyte growth modulation, myelin for-
mation, dendritogenesis, augmentation of glutamatergic synapse transmission, and mitigation of the gamma-
amino butyric acid (GABA) inhibitory signal.10,11
 Animal studies have found that iron deficiency in early life leads to epigenetic changes which alter the structure
 of chromatin and gene expression of BDNF, thus causing a decrease in neuronal differentiation in the
hippocampus. This is also associated with abnormalities of behavior and cognitive function.12 Acute iron
deficiency that occurs in late pregnancy, delivery, and postpartum periods may result in reduction of BDNF and
mitochondrial dysfunc- tion. This can lead to impairment of neuron structure, neuron electrophysiology, and
behavioral development. If the iron deficiency still persists into adulthood, it may also contribute to learning and
memory problems.5,13
 The susceptibility of pregnant women to iron deficien- cy anemia, the positive correlation between maternal and
neonatal ferritin, and the negative effect of iron deficien- cy on brain function have encouraged us to study the
dif- ferences in BDNF among term newborns from mothers with normal and low ferritin.
 METHODS
 This was an observational study with a cross-sectional design. It was conducted from August 2015 to February
 2016 and approved by the Medical Research Ethics Committee of the Dr. M. Djamil Hospital (Project Num- ber
PE.07.2016). Term pregnant patients with normal leukocyte counts and willing to participate were include. The
exclusion criteria were any evidence of infectious disease, vascular disease, kidney disease, diabetes melli- tus,
or vaginal bleeding. Eligible patients were identified through the cooperation of three participating medical
institutions located in Padang, West Sumatra, Indonesia, namely, Yarsi hospital, BMC hospital, and Hardi clinic.
Those who agreed to participate in the study gave written informed consent and had their blood checked for
serum
 ferritin. A total of 40 pregnant women participated, 20 with normal serum ferritin (>12 ng/mL) and 20 with low
serum ferritin (<12 ng/mL).
 All participants were followed until delivery and the cord-blood of their newborns was examined immediately t
after birth for BDNF using an enzyme-linked immuno- sorbent assay (ELISA) method available in the Biomedi-
cal Laboratory of the Medical faculty of Andalas Univer- sity. Independent sample t-tests were used to assess
sig- nificant difference (SPSS program (22.0 version).
 RESULTS
 Maternal characteristics are shown in Table 1.There were no differences in age, parity, Body Mass Index (BMI)
or leukocyte counts between normal and low ferritin groups (p>0.05). However, there was a significant
difference in hemoglobin between the two groups (p<0.05).
 Neonatal characteristics are shown in Table 2. The dif- ferences in birth weight, body length, and head circum-
ference among newborns from mothers with normal and low ferritin were not statistically significant (p>0.05).
There was a significant difference in neonatal BDNF be- tween the normal and low maternal ferritin groups
(p<0.05) (Figure 1).
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DISCUSSION
 As shown in Table 1, we found that those with low ferri- tin had a lower hemoglobin than those with normal
ferri- tin (p<0.05). This is consistent with a study by Milman et al (1991) which was a placebo controlled study
of 207 healthy Danish women after 16 week gestation. They reported that the placebo-treated group had a lower
he-
 Table 1. The maternal characteristics by maternal ferritin
 Characteristics Normal ferritin (≥12 ng/mL) Low ferritin (<12 ng/mL) p value*
 N=20 N=20
 Age (years)† 31.1±5.42 29.9±5.29 0.268
 Parity‡
 Primipara 10 (50%) 13 (65%) 0.344
 Multipara 10 (50%) 7 (35%)
 BMI (kg/m2)† 23.0±2.13 23.1±4.34 0.355
 Hb (gr/L)† 109±6.9 101±12.3 0.025
 Leukocytes (109/L)† 9.7±1.7 10.3±2.0 0.319
 BMI: body mass index; Hb: haemoglobin.
 †Data are reported as mean±SD.
 ‡Data are reported as percentage.
 *p values are obtained by independent t-test.
 Table 2. The neonatal characteristics by maternal ferritin
 Normal ferritin (≥12 ng/mL) Low ferritin (<12 ng/mL) Mean differenece *
 Sex†
 N=20 N=20 (95% CI) p value
 Men
 9 (45%)
 15 (75%)
 Women
 11 (55%)
 5 (25%)
 Birth weight (kg)‡
 3.16±0.31
 3.29±0.34
 124 (87.1-336)
 0.241
 Body length (cm)‡
 48.8±2.09
 48.4±1.73
 0.40 (0.33-1.63)
 0.319
 Head circumference (cm)‡
 34.4±0.59
 34.3±0.470
 0.1 (0.04-0.44)
 0.667
 BDNF serum (ng/mL)‡
 3.81±1.37
 2.78±1.19
 1.03 (0.21-1.86)
 0.015
 BDNF: brain-derived neurotrophic factor; CI: confidence interval.
 †Data are reported as percentage.
 ‡Data are reported as mean±SD.
 *p values are obtained by independent t-test.
 Figure 1. Differences in mean level of Brain Derived Neurotrphic Factor (BDNF) between the newborns babies
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from mother with normal
 ferritin levels and low ferritin levels.
 moglobin than the iron-treated group (p<0.001). Sao et al (2012) conducted a study in Southeastern China of
3702 pregnant women after 37 week gestation. They found that maternal anemia (Hb <11 g/dL) was present in
27.5% women and associated with low maternal serum ferritin (<20 ng/mL) in 86.9% women.6,9
 Iron plays an important role in the synthesis of neuro- transmitters such as serotonin, norepinephrine, and do-
pamine that are essential for the synthesis of BDNF.11
 Acute iron deficiency that occurs in late pregnancy and postpartum will interfere with neuronal structure and
electrophysiology. As indicated above, if the iron defi- ciency persists into adulthood, learning and memory dis-
orders may supervene.5,12 The associated decrease in BDNF expression compromises neuron differentiation in
several brain areas. This underscores the importance of iron homeostasis from the commencement of central
nervous system (CNS) intrauterine development.12
 The observed association of lower neonatal BDNF with a low maternal ferritin is biologically plausible. Serum
ferritin has a direct correlation with the total amount of iron stored in the body. Maternal iron deficiency during
pregnancy has a negative effect on fetal iron homeostasis. Iron transfer from mother to fetus is a regulated
process involving iron status in the maternal circulation, its transport across the placenta and subsequent transfer
into the fetal circulation. The resulting iron deficiency in neo- nates may decrease the expression and function
BDNF in specific areas of the brain and be reflected in a low plas- ma BDNF. Similar to the present findings,
Gaspar found that cord-blood ferritin in neonates born to mothers with low serum ferritin was lower than in
those born to moth- ers with normal serum ferritin.7 This is also in accordance with studies conducted by Perez
in 2005 and Shao in
 2012 who found that positive correlations between mater- nal serum ferritin and the iron reserve of term
neonates.8,9
 Given the role of BDNF in learning and memory, it is imperative that all pregnant women should be given iron
replete not only to prevent any iron deficiency-related morbidity, but also to provide the mother the optimal op-
portunity of having intelligent offspring. The World
 Health Organization (WHO) recommends a daily sup- plement of 30 to 60 mg of elemental iron as part of the
antenatal care in settings where anemia in pregnant wom- en is a public health problem. A higher dose may be
nec- essary if the pregnant women is diagnosed with anemia and until her hemoglobin concentration becomes
nor- mal.14
 A limitation of our study is the absence of neonatal fer- ritin data so that the direct relationship between maternal
and neonatal ferritin could not be determined. Whether the decreased neonatal BDNF was attributable to de-
creased neonatal ferritin could not be determined.
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Analyses of Nutrients and Body Mass Index as Risk Factor for Preeclampsia
 Introduction
 Preeclampsia is an important problem in obstetrics because it is still a major cause of maternal mortality
compared to bleeding and infection. Preeclampsia leads to maternal and perinatal morbidity. Preeclampsia is
also associated with high rates of preterm delivery, small for gestational ages, and perinatal death [1]. Little is
known about the patho- genesis of preeclampsia. Many factors are identified as risk factors for preeclampsia
including parity, multiple preg- nancies, age, family history of preeclampsia, obesity, his- tory of systemic
disease, and nutrition.
 Since preeclampsia is characterized by reduced perfu- sion of the placenta, oxidative stress, and endothelial dys-
function, nutrition has long been hypothesized to have a role in the etiology of preeclampsia [2]. Oxidative
stresses are proposed as the linkage between the two stages of preeclampsia. Nutrients can affect oxidative stress
by increasing or decreasing free radicals or antioxidants or by providing substrate for the formation of free
radicals. Several nutrients, particularly omega-3 (n - 3) fatty acids, antioxidants, and folic acid, have an
important roles in modulating endothelial function. It has also been suggested that nutrients such as trace
elements, fatty acids, and folic acid can contribute to insulin resistance, a risk factor for preeclampsia. In many
studies, decrease in serum magne- sium levels has been considered as the cause of patho- genesis of
preeclampsia. Minerals have an important
 influence on the health of pregnant women and growing fetus. Among them, serum or placental zinc (Zn)
concen- trations have been reported to be low in PE women. Fur- thermore, decreased levels of zinc, selenium,
and copper have been observed in patients with preeclampsia [3]. In another side, the nutrients with antioxidants
among high risk women showed a protective effect [4]. Folic acid has been hypothesized as a protective agent of
preeclampsia.
 Maternal obesity and insulin resistance are also believed to be important risk factors for the development of pla-
cental endothelial dysfunction and preeclampsia. Preven- tion of preeclampsia has remained elusive, owing
largely to their complex nature. Currently, maternal obesity in prepregnancy is one of the strongest modifiable
risk fac- tors. Recent studies have shown a relation between obesity in prepregnancy and the risk of
preeclampsia. The reason for obesity being associated with an increased risk of preeclampsia was explained by
increased levels of serum triglycerides and very low-density lipoprotein particles in obese women. This lipid
alterations have been suggested to promote oxidative stress caused by ischemia–reperfusion mechanism or
activated neutrophils, which leads to endothelial cell dysfunction [1].
 The hypothesis about nutritional status and body mass index (BMI) prepregnancy associated with preeclampsia
has intrigued us to study the risk factor for preeclampsia in Dr. M. Djamil Hospital, Padang, Indonesia.
 Methods
 This was a case–control study at the Department of Obstetric and Gynecology in Dr. M. Djamil Hospital,
Padang, Indonesia, between January and December 2013. Pregnant women after 20 weeks gestations were
included. A total of 140 patients were enrolled in this study with 70 cases and 70 controls. Cases were those
diagnosed with preeclampsia; meanwhile, controls were normotensive pregnant women without any other
comorbidity.
 After providing written informed consent, all subjects completed an interview for their nutritional status and
prepregnancy BMI after delivery. The nutritional status was assessed by Food Frequency Questionnaire (FFQ)
and then analyzed by Nutrisurvey Program. Calories, protein, fat, carbohydrates, calcium, phosphorus, zinc,
sodium, potassium, magnesium, vitamin A, folic acid, vitamin B1, vitamin B2, niacin, vitamin B6, vitamin B12,
vitamin C, and vitamin E were assessed. Maternal BMI was catego- rized into two groups: normal BMI and
abnormal BMI. Normal BMI was defined as 18.5–24.9 kg/m2. The inde- pendent samples t test was used for
nutritional status, and
 Chi-square test was used for BMI. Odds ratio (OR) with
 95% CI was calculated. A p value \0.05 was considered
 statistically significant. For the nutrition variable, if the p value \0.25 then continued by logistic regression back-
ward to assess the risk factor.
 Results
 Most of the subjects had normal weight, both in case and control groups. Table 1 shows that prevalence of
abnormal BMI was more common in the preeclampsia group com- pared with those without preeclampsia 19
(27.1%) versus
 12 (17.1%). BMI was not found as a significant risk factor in this study (p = 0.222).
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As shown in Table 2, the mean level for most of the
 variables, except calories, fat, and vitamin B1, was lower in subjects with preeclampsia than those without
preeclamp- sia. The difference for most of the subjects was also sta- tistically significant with p \ 0.05, except for
vitamin B1 and vitamin B2. Table 3 shows the risk factors for preeclampsia obtained by logistic regression
analyses. The nutrients that were significantly associated with increased risk of preeclampsia were deficiency of
vitamin E, zinc, fat, calcium, and vitamin C. Excess of calories and carbohy- drate also significantly associated
with increased risk of preeclampsia. Meanwhile, vitamin A and vitamin B1 were protective factors.
 Discussion
 The reason for obesity being associated with an increased risk of preeclampsia was explained by increased levels
of serum triglycerides, very low-density lipoproteins, and formation of small low-density lipoprotein particles in
obese women. This lipid profile was also found in women with preeclampsia. These lipid alterations have been
suggested to promote oxidative stress, caused by ische- mia–reperfusion mechanism or activated neutrophils,
which leads to endothelial cell dysfunction [1]. Moreover, dyslipidemia also can cause atherothrombosis and
induce the aggregation of the thrombocytes than can lead to coagulopathy which is a characteristic of
preeclampsia.
 Obesity is accompanied by oxidative stress. The origin of oxidative stress is proposed to be secondary to
increased free fatty acids and inflammation. It is also suggested that diet can contribute to oxidative stress.
Obese individuals have lower blood concentrations of antioxidants. This could be due to reduced dietary intake
of antioxidants, but increased consumption by reactive oxygen species is also possible [5].
 In this study, we found no relationship between BMI with preeclampsia. As mentioned before, dyslipidemia is
the important factor that can lead into preeclampsia. But our study did not assess profile lipid of the subjects.
Fur- thermore, central obesity has a higher risk of preeclampsia. Central obesity is characterized by visceral fat.
Visceral fat produces C-reactive protein (CRP), PAI-1, and leptin that contributes to oxidative stress. People with
central obesity have a higher risk to get preeclampsia. In this study, we did not assess the central obesity of the
subjects. Measures of body composition, including percent body fat, may very likely identify the obese woman
at risk of preeclampsia more accurately.
 Our study found that carbohydrate intake in preeclampsia group was significantly higher than the non-
preeclampsia group. The subjects that have higher carbo- hydrate will have lower protein level. Meanwhile,
protein is needed in the process of trophoblast invasion so the protein-energy malnutrition increases the risk of
preeclampsia. We also found that intake of proteins in preeclampsia was significantly lower in the preeclampsia
group.
 Folic acid and vitamin B12 are also a protector factors against preeclampsia. Those micronutrients play an
important role in suppressing the metabolism of homo- cysteine, whereas the excess of homocysteine was a cau-
sative factor of endothelial damage and became one of the causes of preeclampsia. In addition, folic acid-
supple- ments preconception enhance the placentation process and can prevent preeclampsia. Three earlier
cohort studies assessed the effect of folic acid containing multivitamins (including folic acid) and gestational
hypertension (in- cluding preeclampsia), and all showed a protective effect of folic acid supplementation on
preeclampsia [2, 6, 7].
 Table 1 Asssociation between body mass index and the risk of preeclampsia
 BMI
 Preeclampsia
 %
 Non-preeclampsia
 %
 p*
 OR
 CI 95%
 Min.
 Max.
 Abnormal BMI
 19
 27.1
 12
 17.1
8/2/2018 Comparison of 01.Analyses_of_Nutrients.docx with 04.Differences_in_brain.docx (Matched Words = 64)
file:///F:/yusra/01.Analyses_of_Nutrients.docx.04.Differences_in_brain.docx.html 3/6
0.222
 1.801
 0.797
 4.067
 Normal BMI
 51
 72.9
 58
 82.9
 70
 100
 70
 100
 BMI body mass index, OR odds ratio, CI confidence interval
 * p value were obtained by Chi-square
 Table 2 Differences of mean nutritions level in preeclampsia and non-preeclampsia group
 Preeclampsia
 Mean (95% CI)
 Non-preeclampsia
 Mean (95% CI)
 p*
 Calorie (Kcal)
 1269.22 (745.2–2214)
 1171.15 (649.1–2447.6)
 0.048
 Protein (g)
 42.37 (23.03–95.42)
 54.9 (24.2–200.6)
 0.000
 Fat (g)
 26.8 (4.65–58.9)
 32.4 (10.79–93.12)
 0.009
 KH (g)*
 219.5 ± 56.8
 163.49 ± 46.5
 0.000
 Calcium (mg)
 234.7 (63.7–758.3)
 9362.9 (63.7–922.4)
 0.000
 Phosphor (mg)
 589.4 (296.5–1444.5)
 714.6 (324.6–2353.4)
 0.006
 Fe (mg)
 9.4 (2.84–23.9)
 11.06 (2.84–35.6)
 0.005
 Zinc (mg)
 4.8 (2.39–12.87)
 5.5 (2.4–16.5)
 0.005
 Natrium (mg)
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299.3 (76.9–970.24)
 533.3 (105.9–1847.60)
 0.000
 Kalium (mg)*
 595.4 ± 237.2
 732.15 ± 367.8
 0.010
 Magnesium (mg)
 181.1 (97.1–370.14)
 210.0 (97.1–554.5)
 0.010
 Vitamin A (lg)
 544.9 (174.9–1567.4)
 763.9 (174.9–3354.5)
 0.000
 Folic acid (lg)
 108.6 (56.8–421.6)
 163.5 (56.83–497.9)
 0.000
 Vitamin B1 (mg)
 0.7 (0.27–2.15)
 0.65 (0.27–2.01)
 0.085
 Vitamin B2 (mg)
 0.94 (0.25–2.45)
 1.1 (0.25–2.7)
 0.046
 Niacin (mg)
 4.3 (0.6–11.9)
 5.8 (2.1–23.7)
 0.000
 Vitamin B6 (mg)
 1.1 (0.66–2.14)
 1.22 (0.67–3.8)
 0.009
 Vitamin B12 (mg)
 1.1 (0.15–9.15)
 2.8 (0.27–21.1)
 0.000
 Vitamin C (mg)
 43.4 (8.4–136.8)
 68.2 (19.2–262.7)
 0.000
 Vitamin E (mg TE)
 1.9 (0.2–4.4)
 3.6 (1.8–8.2)
 0.000
 CI confidence interval
 * p value was obtained by independent samples t test
 A recent large cohort study from Denmark also showed that regular use of folic acid in pregnancy was related to
a reduced risk of preeclampsia among normal-weight women [8]. But in this study, we did not found the folic
acid and vitamin B12 as a protective agent of preeclampsia. The different result maybe caused by
supplementation that has been done generally. In other side, the no supplementation subject was rare so that
selection bias/confounding become difficult to control.
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The previous study showed that vitamin B6 deficiency is associated with cardiovascular disease. This is related
to the function of B6 for the establishment of pyridoxal 5 phosphate which is an essential coenzyme in many
meta- bolism processes. The coenzyme deficiency will lead to the diseases such as preeclampsia. Another
micronutrients that play a role in the occurrence of preeclampsia is magne- sium. In a study, obtained serum
magnesium levels in patients with preeclampsia were significantly lower than normal pregnancy. This indicates
that magnesium as one of the predictors of preeclampsia. Magnesium also allegedly acted as a coenzyme
intracellular and functions to maintain contraction and vascular tone [2].
 Serum zinc, calcium, and magnesium levels have been compared between preeclamptic and healthy pregnant
women in various studies. Some results showed that copper, zinc, and
 calcium levels were significantly lower in preeclamptic patient, whereas magnesium concentrations showed no
sig- nificant differences between the two groups [9]. Our study is consistent with that study, whereas we found
zinc and calcium deficiency as a risk factor for preeclampsia (OR 99.46, 95% CI
 1.37, 7219; OR 31, 95% CI 1.21, 841).
 Our study found that vitamin E and A deficiency increase the risk of preeclampsia (OR 19.57, 95% CI
 2.5, 151, OR 1768, 95% CI 10.22, 305,890). Antioxi-
 dants are important in maintaining cellular integrity in a normal pregnancy by inhibiting peroxidation reaction
and thus protecting enzymes, proteins, and cells from destruction by peroxides. Antioxidant defense mecha-
nisms include cellular and extracellular enzymes such as free radical scavengers, including vitamin C and E, and
metabolites such as bilirubin and uric acid. Vitamin C and E are antioxidants derived from the diet. Vitamin C
scavenges free radicals in the aqueous phase, and the lipid-soluble vitamin E acts in vivo to prevent the for-
mation of lipid peroxides and thus protect cell mem- branes. There is evidence of oxidative stress in women with
established preeclampsia, including increased plasma concentration of 8-epi-prostaglandin F2a, lipid peroxides,
and decreased concentrations of antioxidants such as vitamins C and E [10].
 Table 3 Results of multivariate logistic regression analysis
 OR p 95% confidence interval
 Calorie
 3.87
 0.028
 2.39 ± 6,268,293
 Protein
 0.049
 0.650
 0.27 ± 12,994
 Fat
 59.182
 0.138
 3.14 ± 500
 KH
 52.9
 0.063
 0.801 ± 3495
 Calcium
 109
 0.119
 0.29 ± 40,041
 Fe
 9.84
 0.149
 0.441 ± 219
 Zinc
 99.4
 0.035
 1.37 ± 7219
 Natrium
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0.62
 0.731
 0.041 ± 9.37
 Kalium
 0.005
 0.054
 0.000 ± 1.08
 Magnesium
 0.015
 0.528
 0.000 ± 7321
 Vitamin A
 0.002
 0.055
 0.000 ± 1.14
 Folic acid
 42.9
 0.193
 0.15 ± 12,383
 Vitamin B1
 0.000
 0.009
 0.000 ± 0.014
 Vitamin B2
 3.75
 0.550
 0.049 ± 285
 Niacin
 2.39
 0.068
 0.571 ± 1E ? 007
 Vitamin B6
 0.299
 0.591
 0.004 ± 24.3
 Vitamin B12
 4.511
 0.243
 0.36 ± 56.4
 Vitamin C
 19.5
 0.004
 2.52 ± 151
 Vitamin E
 1.76
 0.004
 10.2 ± 30.5
 OR odds ratio
 Conclusions
 Deficiency of vitamin E, zinc, fat, calcium, and vitamin C, and excess of calories and carbohydrate were
associated with increased risk of preeclampsia.
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Differences in brain-derived neurotrophic factor between neonates born to mothers with normal and low ferritin
 INTRODUCTION
 Nutrition plays a role in the intellectual development of a child during intrauterine life. The most common nutri-
tional deficiency found in pregnant women is iron defi- ciency.1,2 Pregnancy is a condition that increases the
iron requirement to meet fetal and placental needs. Insuffi- cient iron stores before pregnancy and inadequate
iron intake during pregnancy can lead to iron deficiency ane- mia.3 The iron deficiency can be examined by
assessing the serum ferritin that directly correlates with the total amount of iron stored in the body. Iron
deficiency anemia is usually found when the serum ferritin is less than 12 μg/dL.4,5
 A study by Milman et al (1991) suggested that neonates born to mothers receiving iron supplementation during
pregnancy had higher serum ferritin than neonates born to mothers receiving placebo.6 Consistent with the
previous study, Gaspar et al (1993) and Perez et al (2005) reported that neonates born to mothers with low serum
ferritin tend to have low serum ferritin as well.7,8 Shao et al (2012) also found that there was a positive
correlation between maternal serum ferritin and iron reserve in term neonates.9
 Iron deficiency is associated with decreased intellectual or cognitive function. The brain region that serves as a
 center of memory, learning, and behavior is the hippo- campus. Iron is essential for the hippocampus to under-
take dendritogenesis, synaptogenesis, neurogenesis, and synthesis of neurotrophic factors that facilitate brain
growth and development commencing in intrauterine life. The main neurotrophic factor in the hippocampus for
learning, memory, and behavior is brain-derived neu- rotrophic factor (BDNF). BDNF is a family of neurotro-
phins that plays an important role in neuronal cell plas- ticity, oligodendrocyte growth modulation, myelin for-
mation, dendritogenesis, augmentation of glutamatergic synapse transmission, and mitigation of the gamma-
amino butyric acid (GABA) inhibitory signal.10,11
 Animal studies have found that iron deficiency in early life leads to epigenetic changes which alter the structure
 of chromatin and gene expression of BDNF, thus causing a decrease in neuronal differentiation in the
hippocampus. This is also associated with abnormalities of behavior and cognitive function.12 Acute iron
deficiency that occurs in late pregnancy, delivery, and postpartum periods may result in reduction of BDNF and
mitochondrial dysfunc- tion. This can lead to impairment of neuron structure, neuron electrophysiology, and
behavioral development. If the iron deficiency still persists into adulthood, it may also contribute to learning and
memory problems.5,13
 The susceptibility of pregnant women to iron deficien- cy anemia, the positive correlation between maternal and
neonatal ferritin, and the negative effect of iron deficien- cy on brain function have encouraged us to study the
dif- ferences in BDNF among term newborns from mothers with normal and low ferritin.
 METHODS
 This was an observational study with a cross-sectional design. It was conducted from August 2015 to February
 2016 and approved by the Medical Research Ethics Committee of the Dr. M. Djamil Hospital (Project Num- ber
PE.07.2016). Term pregnant patients with normal leukocyte counts and willing to participate were include. The
exclusion criteria were any evidence of infectious disease, vascular disease, kidney disease, diabetes melli- tus,
or vaginal bleeding. Eligible patients were identified through the cooperation of three participating medical
institutions located in Padang, West Sumatra, Indonesia, namely, Yarsi hospital, BMC hospital, and Hardi clinic.
Those who agreed to participate in the study gave written informed consent and had their blood checked for
serum
 ferritin. A total of 40 pregnant women participated, 20 with normal serum ferritin (>12 ng/mL) and 20 with low
serum ferritin (<12 ng/mL).
 All participants were followed until delivery and the cord-blood of their newborns was examined immediately t
after birth for BDNF using an enzyme-linked immuno- sorbent assay (ELISA) method available in the Biomedi-
cal Laboratory of the Medical faculty of Andalas Univer- sity. Independent sample t-tests were used to assess
sig- nificant difference (SPSS program (22.0 version).
 RESULTS
 Maternal characteristics are shown in Table 1.There were no differences in age, parity, Body Mass Index (BMI)
or leukocyte counts between normal and low ferritin groups (p>0.05). However, there was a significant
difference in hemoglobin between the two groups (p<0.05).
 Neonatal characteristics are shown in Table 2. The dif- ferences in birth weight, body length, and head circum-
ference among newborns from mothers with normal and low ferritin were not statistically significant (p>0.05).
There was a significant difference in neonatal BDNF be- tween the normal and low maternal ferritin groups
(p<0.05) (Figure 1).
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DISCUSSION
 As shown in Table 1, we found that those with low ferri- tin had a lower hemoglobin than those with normal
ferri- tin (p<0.05). This is consistent with a study by Milman et al (1991) which was a placebo controlled study
of 207 healthy Danish women after 16 week gestation. They reported that the placebo-treated group had a lower
he-
 Table 1. The maternal characteristics by maternal ferritin
 Characteristics Normal ferritin (≥12 ng/mL) Low ferritin (<12 ng/mL) p value*
 N=20 N=20
 Age (years)† 31.1±5.42 29.9±5.29 0.268
 Parity‡
 Primipara 10 (50%) 13 (65%) 0.344
 Multipara 10 (50%) 7 (35%)
 BMI (kg/m2)† 23.0±2.13 23.1±4.34 0.355
 Hb (gr/L)† 109±6.9 101±12.3 0.025
 Leukocytes (109/L)† 9.7±1.7 10.3±2.0 0.319
 BMI: body mass index; Hb: haemoglobin.
 †Data are reported as mean±SD.
 ‡Data are reported as percentage.
 *p values are obtained by independent t-test.
 Table 2. The neonatal characteristics by maternal ferritin
 Normal ferritin (≥12 ng/mL) Low ferritin (<12 ng/mL) Mean differenece *
 Sex†
 N=20 N=20 (95% CI) p value
 Men
 9 (45%)
 15 (75%)
 Women
 11 (55%)
 5 (25%)
 Birth weight (kg)‡
 3.16±0.31
 3.29±0.34
 124 (87.1-336)
 0.241
 Body length (cm)‡
 48.8±2.09
 48.4±1.73
 0.40 (0.33-1.63)
 0.319
 Head circumference (cm)‡
 34.4±0.59
 34.3±0.470
 0.1 (0.04-0.44)
 0.667
 BDNF serum (ng/mL)‡
 3.81±1.37
 2.78±1.19
 1.03 (0.21-1.86)
 0.015
 BDNF: brain-derived neurotrophic factor; CI: confidence interval.
 †Data are reported as percentage.
 ‡Data are reported as mean±SD.
 *p values are obtained by independent t-test.
 Figure 1. Differences in mean level of Brain Derived Neurotrphic Factor (BDNF) between the newborns babies
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from mother with normal
 ferritin levels and low ferritin levels.
 moglobin than the iron-treated group (p<0.001). Sao et al (2012) conducted a study in Southeastern China of
3702 pregnant women after 37 week gestation. They found that maternal anemia (Hb <11 g/dL) was present in
27.5% women and associated with low maternal serum ferritin (<20 ng/mL) in 86.9% women.6,9
 Iron plays an important role in the synthesis of neuro- transmitters such as serotonin, norepinephrine, and do-
pamine that are essential for the synthesis of BDNF.11
 Acute iron deficiency that occurs in late pregnancy and postpartum will interfere with neuronal structure and
electrophysiology. As indicated above, if the iron defi- ciency persists into adulthood, learning and memory dis-
orders may supervene.5,12 The associated decrease in BDNF expression compromises neuron differentiation in
several brain areas. This underscores the importance of iron homeostasis from the commencement of central
nervous system (CNS) intrauterine development.12
 The observed association of lower neonatal BDNF with a low maternal ferritin is biologically plausible. Serum
ferritin has a direct correlation with the total amount of iron stored in the body. Maternal iron deficiency during
pregnancy has a negative effect on fetal iron homeostasis. Iron transfer from mother to fetus is a regulated
process involving iron status in the maternal circulation, its transport across the placenta and subsequent transfer
into the fetal circulation. The resulting iron deficiency in neo- nates may decrease the expression and function
BDNF in specific areas of the brain and be reflected in a low plas- ma BDNF. Similar to the present findings,
Gaspar found that cord-blood ferritin in neonates born to mothers with low serum ferritin was lower than in
those born to moth- ers with normal serum ferritin.7 This is also in accordance with studies conducted by Perez
in 2005 and Shao in
 2012 who found that positive correlations between mater- nal serum ferritin and the iron reserve of term
neonates.8,9
 Given the role of BDNF in learning and memory, it is imperative that all pregnant women should be given iron
replete not only to prevent any iron deficiency-related morbidity, but also to provide the mother the optimal op-
portunity of having intelligent offspring. The World
 Health Organization (WHO) recommends a daily sup- plement of 30 to 60 mg of elemental iron as part of the
antenatal care in settings where anemia in pregnant wom- en is a public health problem. A higher dose may be
nec- essary if the pregnant women is diagnosed with anemia and until her hemoglobin concentration becomes
nor- mal.14
 A limitation of our study is the absence of neonatal fer- ritin data so that the direct relationship between maternal
and neonatal ferritin could not be determined. Whether the decreased neonatal BDNF was attributable to de-
creased neonatal ferritin could not be determined.
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 Research Article
 Differences in Mean Levels of Maternal Resistin Serum between
 Early Onset Preeclampsia (EOPE) and Late Onset Preeclampsia
 (LOPE)
 INTRODUCTION
 Preeclampsia is one of the major causes of morbidity
 and mortality of the mother and fetus. World Health
 Organization (WHO) reported the number of deaths caused by
 preeclampsia by 16% in developing countries
 . Preeclampsia
 resulting 3-25 fold increased risk obstetric complications
 and is the cause of 30-40% of perinatal deaths in Indonesia
 1
 .
 The incidence of preeclampsia ranges between 5-10%
 of all pregnancies
 . Incidence of preeclampsia in the United
 States, Canada and Western Europe ranges between 2-5%
 of all pregnancies and higher, 4-18% in some developing
 countries in Africa
 1
 . The incidence of preeclampsia in
 Indonesia ranged between 3-10%
 3
 .
 In Dr.M. Djamil General Hospital in Padang during the
 2
 year 2011, the incidence of preeclampsia was 8.31%, on 2012
 was 11.47% and on 2013 was 12.02%.
 Preeclampsia is divided into early onset preeclampsia
 (EOPE) (<34 weeks) and late onset preeclampsia (LOPE)
 (>34 weeks) of pregnancy based on the onset of clinical
 manifestations of preeclampsia. The EOPE and LOPE has a
 different pathogenesis. The PEAD is often associated with
 impaired uteroplacental perfusion caused by disruption of
 trophoblast invasion, while LOPE is often associated with the
 presence of extrinsic and maternal factors
 .
 Preeclampsia is a protean syndrome, in which multiple
 4,5
 organ systems can be affected compared to the others.
 Preeclampsia is mainly characterized by hypertension and
 proteinuria or may be associated with abnormalities in
 laboratory test results that renal function, hepatic or
 hemostasis after 20 weeks of pregnancy
 .
 Analysis of risk factor for preeclampsia is needed to
 1,6
 mitigate the adverse effects of preeclampsia. One among
 of these risk factor is resistin which is associated with
 inflammation and insulin resistance, so that resistin was a
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maternal risk factor that associated with LOPE
 .
 Resistin is an adipose tissue-specific secretory factor
 7
 (ADSF), a hormone secreted by adipose tissue that induces
 insulin resistance in muscle and liver. Resistin stimulated by
 inflammatory conditions that produce proinflammatory
 cytokines
 .
 Preeclampsia is associated with inflammation and insulin
 7,8
 resistance which is affected by resistin. Resistin is associated
 with late onset preeclampsia because it was a maternal
 factors, so there was an increasing of maternal resistin serum
 levels in late onset preeclampsia
 .
 Previous study reported an elevated of maternal resistin
 7,8
 serum levels associated with a systemic inflammatory
 response and insulin resistance which is both of them are
 2
 2
 increased in preeclampsia compared to normal pregnancy
 .
 The other study showed the mean of Homeostasis Model
 Assessment-Insulin Resistance (HOMA-IR) and high sensitivity
 C-reactive protein (hs-CRP) was higher in late onset
 preeclampsia than early onset preeclampsia group.
 From
 various studies on the above it could be estimated that the
 inflammatory factor and insulin resistance are associated
 with higher levels of resistin more dominant in late onset
 preeclampsia group compared to early onset preeclampsia
 group.
 The HOMA-IR could be used as an indicator of insulin
 resistance, but not for inflammatory states, contrary hs-CRP
 could be used as an indicator of inflammation, but not for
 insulin resistance. Resistin is expected to describe both of
 them, because it was associated with insulin resistance and
 inflammation
 7
 .
 MATERIALS AND METHODS
 This study is an analytical cross sectional study with
 2 0 w o me n o f e a r l y o n s e t p r e e c l a mp s i a ( E OP E ) a n d 2 0 w o me n
 of late onset preeclampsia (LOPE) who met the inclusion
 criteria and there were no exclusion criteria. The samples
 were recruited in Dr.M. Djamil General Hospital, Padang from
 July-October, 2015.
 The inclusions criteria were women who detected early
 onset preeclampsia or late onset preeclampsia in obstetrics
 emergency ward of Dr.M. Djamil General Hospital, Padang
 and willing to follow the research for taking blood samples.
 The exclusions criteria were diabetes mellitus (random blood
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sugar as >200 mg dLG
 ), had suffered coronary heart disease,
 chronic kidney disease, chronic liver disease and obesity
 (BMI before pregnancy >25 kg mG
 1
 ).
 Maternal resistin serum was examined by enzyme-linked
 2
 immunosorbent assay (ELISA) method in Biomedic Laboratory
 in Medical Faculty of Andalas University. Statistical analysis
 was conducted by using SPSS program 20th version. The data
 distribution was normal with p>0.05. The differences mean
 levels of maternal resistin serum was analyzed by using
 independent t-test.
 RESULTS
 Characteristics of research subjects: Forty patients of
 research subjects consisted 20 patients of early onset
 preeclampsia (EOPE) and 20 patients of late onset
 preeclampsia (LOPE). Mean levels of maternal age in EOPE
 group is 34.4±5.144 years, whereas in LOPE group is
 32.9±6.324 years with p = 0.416. According to maternal age
 9-12
 Table 1: Characteristics of research subjects between early onset preeclampsia and late onset preeclampsia
 Characteristics EOPE (n = 20) LOPE (n = 20) Total (%) p
 Maternal age group
 <20 years 0 (0%) 0 (0%) 0
 20-35 years 8 (40%) 10 (50%) 45 0.537
 >35 years 12 (60%) 10 (50%) 55
 Maternal age (0±SD) years 34.4±5.144 31.9±6.314 0.416
 Gravidity group
 Primigravid 6 (30%) 7 (35%) 32.5 0.744
 Miltigravid 14 (70%) 13 (65%) 67.5
 Gravidity (0±SD) 2.4±1.314 2.65±1.461 0.573
 BMI group
 Underweight 0 (0%) 0 (0%) 0
 Normoweight 14 (70%) 12 (60%) 65 0.520
 Overweight 6 (30%) 8 (40%) 35
 BMI (0±SD) 22.55±1.595 22.59±1.812 0.946
 Table 2: Mean levels of maternal resistin serum in early onset preeclampsia and
 late onset preeclampsia
 EOPE LOPE
 ---------------------- -----------------------Variable
 Mean SD Mean SD
 Maternal resistin serum (ng mLG
 1
 ) 2.526 1.603 8.891 6.219
 Table 3: Mean levels difference of maternal resistin serum in early onset
 preeclampsia and late onset preeclampsia
 Variable Mean difference CI (95%) p
 Maternal resistin serum (ng mLG
 1
 ) 6.365 3.3835-9.3475 0.000
 groups, study of subjects in early onset preeclampsia
 consists 8 patients (40%) in group of maternal age
8/2/2018 Comparison of 02.Differences_in_Mean.docx with 04.Differences_in_brain.docx (Matched Words = 48)
file:///F:/yusra/02.Differences_in_Mean.docx.04.Differences_in_brain.docx.html 4/7
20-35 years old, 12 patients (60%) in group of maternal age
 >35 years old, none in group of maternal age <20 years old.
 Research subjects of late onset preeclampsia consists of 1 0
 patients (50%) in group of maternal age 20-35 years old, 10
 patients (50%) in group of maternal age >35 years old, none
 in group of maternal age <20 years old.
 Mean levels of gravidity in early onset preeclampsia
 (EOPE) group is 2.4±1.314, whereas in late onset
 preeclampsia (LOPE) group is 2.65±1.461 with p = 0.573.
 According to gravidity groups, study of subjects in early
 onset preeclampsia consists 6 patients (30%) in group of
 primigravida, 14 patients (70%) in group of multigravida.
 Research subjects of l ate onset preecl ampsi a c onsi sts of
 7 patients (35%) in group of primigravida, 13 patients (65%).
 Mean levels of Body Mass Index (BMI) in early onset
 preeclampsia (EOPE) group is 22.551±1.595, whereas in late
 onset preeclampsia (LOPE) group is 22.588±1.4812 kg mG
 with p = 0.946. According to BMI groups, study of subjects in
 EOPE consists 14 patients (70%) in group of normal
 weight, 6 patients (30%) in group of overweight, none in
 group BMI underweight. Research subjects of late onset
 preeclampsia consists 12 patients (60%) in group of normal
 weight, 8 patients (40%) in group of overweight, none in
 group BMI underweight.
 2
 3
 There were no statistically significant differences
 regarding maternal age, group of maternal age, gravidity,
 group of gravidity, BMI and group of BMI characteristic
 between those two groups with p>0.05 showed in Table 1.
 Mean levels of maternal resistin serum in early onset
 preeclampsia and late onset preeclampsia: Mean levels of
 maternal resistin serum was higher in late onset preeclampsia
 vs
 2.526±1.603 ng dLG
 than early onset preeclampsia (8.891±6.219 ng mLG
 1
 ), showed in Table 2.
 Differences in mean levels of maternal resistin serum
 between late onset preeclampsia and early onset
 preeclampsia: The data distribution was normal with
 Kolmogorov Smirnov test. Analysis was performed with
 independent t-test. Table 3 showed the differences in mean
 levels of maternal resistin serum between early onset
 preeclampsia and late onset preeclampsia as 6.365 ng mLG
 with Confidence Interval (CI) 95% 3.384-9.347. There is a high
 significant differences with p<0.001.
 DISCUSSION
 The mean levels of maternal serum resistin in early
 onset preeclampsia (EOPE) group was 2.526±1.603 ng mLG
 whereas in late onset preeclampsia (LOPE) group was
 8.891±6.219 ng mLG
 (Table 2), with a mean difference
 6.365 ng dLG
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1
 1
 , 95% CI 3.384-9.347. Statistical test showed
 p<0.001, that the mean levels of maternal serum resistin
 significantly was higher in LOPE than EOPE (Table 3).
 Resistin is a hormone secreted from adipose tissue that
 induces insulin resistance in muscle and liver. Resistin
 stimulated by inflammatory conditions that produce
 proinflammatory cytokines. Resistin contribute to the
 inflammatory disorders such as coronary heart disease,
 1
 1
 1
 chronic kidney disease and liver cirrhosis as well as insulin
 resistance in diabetes mellitus through the activation of
 proinflammatory cytokines varied which depending on the
 organs affected
 .
 Insulin resistance and inflammation were the condition
 7,8
 associated to preeclampsia. This factor related to the role of
 resistin through the release of proinflammatory cytokines.
 The relationship between resistin and preeclampsia is
 connected by those which is a maternal factor in
 preeclampsia. Therefore, resistin is associated to late onset
 preeclampsia, so the levels of maternal resistin serum was
 increased in late onset preeclampsia
 .
 Inflammation and insulin resistance have been
 7,8
 investigated, that the comparasion between HOMA-IR and
 hs-CRP in EOPE and LOPE. This study reported the results
 that mean levels of HOMA-IR and hs-CRP were higher in
 LOPE compared to EOPE (HOMA IR: 4.86±5.50 vs 3.99±5.97
 and hsCRP: 123.08±38.67 vs 26.54±34.7 mg LG
 ). This study
 suggested that the inflammatory factor and insulin resistance
 were more dominant in LOPE compared to EOPE.
 1
 A s i mi l ar r es ul t s w as r epor t ed i n whi c h t he mean l evel s
 of maternal resistin serum was higher in preeclampsia
 compared to normal pregnancy related to an increase in
 insulin resistance and the response systemic inflammation
 that happened in preeclampsia particularly late onset
 preeclampsia
 .
 A cross sectional study in which two groups of pregnant
 9-12
 women with preeclampsia (n = 15) and normal pregnancy
 (n = 23) demonstrated th mean levels of maternal resistin
 serum was higher in preeclampsia (5.68±0.41 ng mLG
 )
 compared to normal pregnancy (4. 65±0. 32 ng mLG
 ),
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p = 0.028. The mean levels of maternal resistin serum related
 to the mean of HOMA-IR and proinflammatory cytokines
 that were elevated in preeclampsia compared to normal
 pregnancy. T he mean of H OMA-I R ( 2. 5±0. 8 vs 1. 4±0. 1),
 IL-6 (6.34±1.02 vs 2.80±0.31) and TNF-" (1.89±0.18 vs
 1.23±0.10)
 .
 Another cross-sectional study on two groups of
 9
 pregnant women, which were preeclampsia (n = 29) and
 normal pregnancy (n = 30), found that mean levels of
 maternal resistin serum was higher in preeclampsia
 61.98±32.26 ng dLG
 , compared to normal pregnancy
 38.06±31.26 ng dLG
 1
 1
 , p = 0.013. Insulin resistance is thought
 related the increasing the levels of maternal resistin serum,
 because the mean of HOMA-IR was higher in preeclampsia
 compared to normal pregnancy (4:44±4:02 vs 3.99±2.82)
 .
 A cross sectional study was conducted on two groups of
 pregnant women, which are preeclampsia (n = 50) and normal
 pregnancy (n = 50). The median levels of maternal resistin
 1
 1
 10
 4
 serum were higher in preeclampsia 61 ng mLG
 compared to
 normal pregnancy 25.5 ng mLG
 1
 1
 , p = 0.033. Insulin resistance
 is thought related the increasing the levels of maternal
 resistin serum, because the median of HOMA-IR was higher in
 preeclampsia compared to normal pregnancy (4.7 vs 3.6)
 .
 A cross sectional study was conducted on two groups of
 pregnant women, which are preeclampsia (n = 16) and normal
 pregnancy (n = 22). The mean levels of maternal resistin
 serum was higher in preeclampsia (12.06±0.973 ng mLG
 )
 compared t o n ormal p regnancy ( 7. 35±1. 195 ng mLG
 ),
 p = 0.041. Inflammatory factors is thought related the
 increasing the levels of maternal resistin serum in
 preeclampsia. There was an increasing mean levels of
 TNF" in preeclampsia compared to normal pregnancy
 (15.23±0.674 vs 12.84±0.348 ng mLG
 1
 , p = 0.021)
 . Based on
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that description, there was a correlation between previous
 studies and this study
 9-12
 12
 .
 The mean levels of HOMA-IR and hs-CRP were higher in
 late onset preeclampsia than early onset preeclampsia, so
 according to those studies above, the insulin resistance and
 inflammation that were higher in late onset preeclampsia than
 early onset preeclampsia related to the levels of maternal
 resistin serum that was higher in late onset preeclampsia than
 early onset preeclampsia. It was appropriate with the results
 of this research that the mean levels of maternal resistin
 serum in late onset preeclampsia was significantly higher than
 early onset preeclampsia with p<0.001.
 CONCLUSION
 The mean levels of maternal resistin serum was higher
 significantly in late onset preeclampsia (LOPE) compared to
 early onset preeclampsia (EOPE).
 11
 1
 1
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Differences in brain-derived neurotrophic factor between neonates born to mothers with normal and low ferritin
 INTRODUCTION
 Nutrition plays a role in the intellectual development of a child during intrauterine life. The most common nutri-
tional deficiency found in pregnant women is iron defi- ciency.1,2 Pregnancy is a condition that increases the
iron requirement to meet fetal and placental needs. Insuffi- cient iron stores before pregnancy and inadequate
iron intake during pregnancy can lead to iron deficiency ane- mia.3 The iron deficiency can be examined by
assessing the serum ferritin that directly correlates with the total amount of iron stored in the body. Iron
deficiency anemia is usually found when the serum ferritin is less than 12 μg/dL.4,5
 A study by Milman et al (1991) suggested that neonates born to mothers receiving iron supplementation during
pregnancy had higher serum ferritin than neonates born to mothers receiving placebo.6 Consistent with the
previous study, Gaspar et al (1993) and Perez et al (2005) reported that neonates born to mothers with low serum
ferritin tend to have low serum ferritin as well.7,8 Shao et al (2012) also found that there was a positive
correlation between maternal serum ferritin and iron reserve in term neonates.9
 Iron deficiency is associated with decreased intellectual or cognitive function. The brain region that serves as a
 center of memory, learning, and behavior is the hippo- campus. Iron is essential for the hippocampus to under-
take dendritogenesis, synaptogenesis, neurogenesis, and synthesis of neurotrophic factors that facilitate brain
growth and development commencing in intrauterine life. The main neurotrophic factor in the hippocampus for
learning, memory, and behavior is brain-derived neu- rotrophic factor (BDNF). BDNF is a family of neurotro-
phins that plays an important role in neuronal cell plas- ticity, oligodendrocyte growth modulation, myelin for-
mation, dendritogenesis, augmentation of glutamatergic synapse transmission, and mitigation of the gamma-
amino butyric acid (GABA) inhibitory signal.10,11
 Animal studies have found that iron deficiency in early life leads to epigenetic changes which alter the structure
 of chromatin and gene expression of BDNF, thus causing a decrease in neuronal differentiation in the
hippocampus. This is also associated with abnormalities of behavior and cognitive function.12 Acute iron
deficiency that occurs in late pregnancy, delivery, and postpartum periods may result in reduction of BDNF and
mitochondrial dysfunc- tion. This can lead to impairment of neuron structure, neuron electrophysiology, and
behavioral development. If the iron deficiency still persists into adulthood, it may also contribute to learning and
memory problems.5,13
 The susceptibility of pregnant women to iron deficien- cy anemia, the positive correlation between maternal and
neonatal ferritin, and the negative effect of iron deficien- cy on brain function have encouraged us to study the
dif- ferences in BDNF among term newborns from mothers with normal and low ferritin.
 METHODS
 This was an observational study with a cross-sectional design. It was conducted from August 2015 to February
 2016 and approved by the Medical Research Ethics Committee of the Dr. M. Djamil Hospital (Project Num- ber
PE.07.2016). Term pregnant patients with normal leukocyte counts and willing to participate were include. The
exclusion criteria were any evidence of infectious disease, vascular disease, kidney disease, diabetes melli- tus,
or vaginal bleeding. Eligible patients were identified through the cooperation of three participating medical
institutions located in Padang, West Sumatra, Indonesia, namely, Yarsi hospital, BMC hospital, and Hardi clinic.
Those who agreed to participate in the study gave written informed consent and had their blood checked for
serum
 ferritin. A total of 40 pregnant women participated, 20 with normal serum ferritin (>12 ng/mL) and 20 with low
serum ferritin (<12 ng/mL).
 All participants were followed until delivery and the cord-blood of their newborns was examined immediately t
after birth for BDNF using an enzyme-linked immuno- sorbent assay (ELISA) method available in the Biomedi-
cal Laboratory of the Medical faculty of Andalas Univer- sity. Independent sample t-tests were used to assess
sig- nificant difference (SPSS program (22.0 version).
 RESULTS
 Maternal characteristics are shown in Table 1.There were no differences in age, parity, Body Mass Index (BMI)
or leukocyte counts between normal and low ferritin groups (p>0.05). However, there was a significant
difference in hemoglobin between the two groups (p<0.05).
 Neonatal characteristics are shown in Table 2. The dif- ferences in birth weight, body length, and head circum-
ference among newborns from mothers with normal and low ferritin were not statistically significant (p>0.05).
There was a significant difference in neonatal BDNF be- tween the normal and low maternal ferritin groups
(p<0.05) (Figure 1).
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DISCUSSION
 As shown in Table 1, we found that those with low ferri- tin had a lower hemoglobin than those with normal
ferri- tin (p<0.05). This is consistent with a study by Milman et al (1991) which was a placebo controlled study
of 207 healthy Danish women after 16 week gestation. They reported that the placebo-treated group had a lower
he-
 Table 1. The maternal characteristics by maternal ferritin
 Characteristics Normal ferritin (≥12 ng/mL) Low ferritin (<12 ng/mL) p value*
 N=20 N=20
 Age (years)† 31.1±5.42 29.9±5.29 0.268
 Parity‡
 Primipara 10 (50%) 13 (65%) 0.344
 Multipara 10 (50%) 7 (35%)
 BMI (kg/m2)† 23.0±2.13 23.1±4.34 0.355
 Hb (gr/L)† 109±6.9 101±12.3 0.025
 Leukocytes (109/L)† 9.7±1.7 10.3±2.0 0.319
 BMI: body mass index; Hb: haemoglobin.
 †Data are reported as mean±SD.
 ‡Data are reported as percentage.
 *p values are obtained by independent t-test.
 Table 2. The neonatal characteristics by maternal ferritin
 Normal ferritin (≥12 ng/mL) Low ferritin (<12 ng/mL) Mean differenece *
 Sex†
 N=20 N=20 (95% CI) p value
 Men
 9 (45%)
 15 (75%)
 Women
 11 (55%)
 5 (25%)
 Birth weight (kg)‡
 3.16±0.31
 3.29±0.34
 124 (87.1-336)
 0.241
 Body length (cm)‡
 48.8±2.09
 48.4±1.73
 0.40 (0.33-1.63)
 0.319
 Head circumference (cm)‡
 34.4±0.59
 34.3±0.470
 0.1 (0.04-0.44)
 0.667
 BDNF serum (ng/mL)‡
 3.81±1.37
 2.78±1.19
 1.03 (0.21-1.86)
 0.015
 BDNF: brain-derived neurotrophic factor; CI: confidence interval.
 †Data are reported as percentage.
 ‡Data are reported as mean±SD.
 *p values are obtained by independent t-test.
 Figure 1. Differences in mean level of Brain Derived Neurotrphic Factor (BDNF) between the newborns babies
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from mother with normal
 ferritin levels and low ferritin levels.
 moglobin than the iron-treated group (p<0.001). Sao et al (2012) conducted a study in Southeastern China of
3702 pregnant women after 37 week gestation. They found that maternal anemia (Hb <11 g/dL) was present in
27.5% women and associated with low maternal serum ferritin (<20 ng/mL) in 86.9% women.6,9
 Iron plays an important role in the synthesis of neuro- transmitters such as serotonin, norepinephrine, and do-
pamine that are essential for the synthesis of BDNF.11
 Acute iron deficiency that occurs in late pregnancy and postpartum will interfere with neuronal structure and
electrophysiology. As indicated above, if the iron defi- ciency persists into adulthood, learning and memory dis-
orders may supervene.5,12 The associated decrease in BDNF expression compromises neuron differentiation in
several brain areas. This underscores the importance of iron homeostasis from the commencement of central
nervous system (CNS) intrauterine development.12
 The observed association of lower neonatal BDNF with a low maternal ferritin is biologically plausible. Serum
ferritin has a direct correlation with the total amount of iron stored in the body. Maternal iron deficiency during
pregnancy has a negative effect on fetal iron homeostasis. Iron transfer from mother to fetus is a regulated
process involving iron status in the maternal circulation, its transport across the placenta and subsequent transfer
into the fetal circulation. The resulting iron deficiency in neo- nates may decrease the expression and function
BDNF in specific areas of the brain and be reflected in a low plas- ma BDNF. Similar to the present findings,
Gaspar found that cord-blood ferritin in neonates born to mothers with low serum ferritin was lower than in
those born to moth- ers with normal serum ferritin.7 This is also in accordance with studies conducted by Perez
in 2005 and Shao in
 2012 who found that positive correlations between mater- nal serum ferritin and the iron reserve of term
neonates.8,9
 Given the role of BDNF in learning and memory, it is imperative that all pregnant women should be given iron
replete not only to prevent any iron deficiency-related morbidity, but also to provide the mother the optimal op-
portunity of having intelligent offspring. The World
 Health Organization (WHO) recommends a daily sup- plement of 30 to 60 mg of elemental iron as part of the
antenatal care in settings where anemia in pregnant wom- en is a public health problem. A higher dose may be
nec- essary if the pregnant women is diagnosed with anemia and until her hemoglobin concentration becomes
nor- mal.14
 A limitation of our study is the absence of neonatal fer- ritin data so that the direct relationship between maternal
and neonatal ferritin could not be determined. Whether the decreased neonatal BDNF was attributable to de-
creased neonatal ferritin could not be determined.
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Differences in Malondialdehyde and Catalase Activity Levels
 Between Abortion and Normal Pregnancy
 INTRODUCTION
 Abortion is defined as a termination of a pregnancy before
 20 weeks of gestation or when the fetal weight is less than
 500 g. Clinically, the most frequent abortion encountered in the hospital is incomplete abortion. Patients usually
come with bleeding and severe abdominal pain. The second one is threatened abortion. Threatened abortion is
the most common complication in the first half of pregnancy and have incidence about 20-25%. Less than 30%
of the women who experience threatened abortion will end in spontaneous abortion1.
 There are many factors that associated with abortion, so it is hard to determine the exact mechanism. In spite of
many possibilities, there is now a clear evidence that abortion is associated with placental oxidative stress. The
abnormal placentation will lead to placental oxidative stress with resultant destructive effects on the
syncytiotrophoblast. The theory has been proposed as a mechanism involved in the etiopathogenesis of
abortion2.
 The body has many antioxidant systems to defend the excessive Reactive Oxygen Species (ROS) production3.
In a healthy body, ROS and antioxidant remain in balance. When the body has an excessive amount of ROS,
Oxidative Stress (OS) then occurs. An increase in the expression of oxidative stress marker in the trophoblast
was detected in abortion and this was speculated to be a cause of early pregnancy loss4.
 Antioxidant system divided into enzymatic and nonenzymatic group. Catalase (CAT) is one of enzymatic
antioxidant that can remove hydrogen peroxide (H2O2), prevents lipid peroxidation in the cell membrane and
works as free radicals binding5. The CAT role in pregnancy is very important, in early pregnancy CAT plays a
role for implantation by protecting the blastocysts from superoxide radicals in the endometrium. The CAT is also
important for embryonic development and the maintenance of early pregnancy. The CAT level was found
increased during pregnancy and low CAT activity in plasma or placenta found in cases of spontaneous abortion6.
Another study also suggests that low antioxidant level increases the risk of spontaneous abortion7.
 Free radicals are thus highly unstable molecules that have electrons available to react with a various organic
substrate such as lipids, proteins and DNA8. Accumulation of lipid peroxides may cause not only tissue damage
but also some biological events to accelerate the termination of pregnancy. It has been reported that ROS or lipid
peroxide stimulate synthesis of PGF2α that causes uterine contraction6. Oxidative stress has been variably
determined by many ways. The most reliable assessment of free radicals synthesis is using assays directly to
detect the superoxide or other free radical. However, this technique is difficult and require specialized document.
In another side, measurement of the products of oxidative modification product provides the most direct and
possible assessment of oxidative stress. Malondialdehyde
 (MDA) is a metabolite of lipid peroxides that detectable in plasma and was used as an indicator of lipid
peroxidation9. This study was carried out to estimate the mean difference of CAT and MDA in normal
pregnancy, threatened abortion and incomplete abortion.
 MATERIALS AND METHODS
 This was an observational study with cross-sectional design on February-December, 2014. The population was
all pregnant women before 20 weeks gestations were enrolled in the maternity ward of Dr. M. Djamil Hospital
and Dr. Reksodiwiryo Hospital, Padang, Indonesia. Subjects were taken by consecutive sampling method. Cases
were those diagnosed with threatened and incomplete abortion by a specialist doctor. Meanwhile, controls were
normal pregnant women without any other comorbid.
 Exclusion criteria were a mother with hydatidiform mole, uterus disorder, myoma, history of provocating and
recurrent abortion. After providing informed, written consent, subject’s blood was taken from antecubital vein
for analyzed the CAT activity and MDA concentration with spectrophotometry method in Biomedical
Laboratory of Medical Faculty of Andalas University.
 The significant difference among the three groups was analyzed with ANOVA test. If p<0.05 was found, then
the analysis continued with post hoc multiple comparison test to determined the differences between two group.
Statistical analysis was conducted using a computer program.
 RESULTS
 During the study period, 42 blood samples were collected, consisting of 14 subjects with threatened abortion,
 14 subjects with incomplete abortion and 14 subjects with normal pregnancy before 20 weeks gestations. Table 1
shows the activity of CAT enzyme in incomplete abortion group was
 51.10±12.20 IU mgG1, the threatened abortion group was
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66.46±9.11 IU mgG1, whereas normal pregnancy group was
 78.26±8.88 IU mgG1. The analysis with statistical tests ANOVA found that p<0.001. To saw the specific
difference between two subjects, the analysis continued by post hoc multiple comparisons test. As presented in
Table 2, there were significant differences of CAT activity between incomplete abortion group and threatened
abortion (p<0.001), incomplete abortion and normal pregnancy (p<0.001), threatened abortion and normal
pregnancy (p = 0.01).
 Table 1: Difference of catalase activity in incomplete abortion, threatened
 abortion and normal pregnancy Catalase activity
 Parameters Mean±SD (IU mgG1) 95% CI p-value*
 Incomplete abortion 51.10±12.20 44.06-58.15 <0.001
 Threatened abortion 66.46±9.11 61.20-71.72
 Normal pregnancy 78.26±8.88 73.13-83.38
 *p-values are obtained by ANOVA test, SD: Standard deviation, CI: Confidence interval
 Table 2: Post hoc test for the difference of the mean level of catalase activity
 in incomplete abortion, threatened abortion and normal pregnancy Incomplete Threatened Normal
 Parameters abortion abortion pregnancy
 Incomplete abortion - <0.001* <0.001* Threatened abortion <0.001* - 0.01* Normal pregnancy <0.001* 0.01* -
 *p-value obtained by Tukey’s test to determine the difference between two groups
 Table 3: Difference of malondialdehyde level in incomplete abortion,
 threatened abortion and normal pregnancy Malondialdehyde level
 Parameters Mean±SD (nmol mLG1) 95% CI p-value*
 Incomplete abortion 4.02±0.36 3.81-4.23 <0.001
 Threatened abortion 3.46±0.39 3.24-3.68
 Normal pregnancy 2.83±0.21 2.71-2.96
 *p-values are obtained by ANOVA test, SD: Standard deviation, CI: Confidence interval
 Table 4: Post hoc Test for the difference of the mean level of malondialdehyde in incomplete abortion,
threatened abortion and
 normal pregnancy Incomplete Threatened Normal
 Parameters abortion abortion pregnancy
 Incomplete abortion - <0.001* <0.001* Threatened abortion <0.001* - <0.001* Normal pregnancy <0.001*
<0.001* -
 *p-value obtained by Tukey’s test to determine the difference between two groups
 As presented in Table 3, the mean level of MDA in incomplete abortion group was 4.02±0.36 nmol mLG1, the
threatened abortion group was 3.46±0.39 nmol mLG1, whereas in normal pregnancy group was 2.83±0.21 nmol
mLG1 with p = 0.00 by ANOVA test. To saw the difference between two group analysis continued with post hoc
test. According to the Table 4, it was found that there were significant differences of MDA level between
incomplete abortion with threatened abortion (p<0.001), incomplete abortion and normal pregnancy group
(p<0.001), threatened abortion and normal pregnancy (p<0.001).
 DISCUSSION
 In this study, it was found that the mean of MDA level of incomplete abortion was higher than threatened
abortion and normal pregnancy (p<0.05). Meanwhile, the mean level of CAT activity was lower in incomplete
abortion than threatened abortion and normal pregnancy (p<0.05).
 This study was accordance with a study conducted by Abdul-Barry et al.8 that found the serum MDA level was
significantly higher in patients with a history of recurrent spontaneous abortion than women with a healthy
pregnancy. Ozkaya et al.10 also reported that the spontaneous abortion before 8 weeks gestation was associated
with higher serum of MDA than healthy pregnancy (66.4±13.7 vs. 40.3±16.1, p<0.01). Because MDA is a side
product of lipid peroxidation, the increase in MDA level may reflect an overproduction of lipid peroxides and
alter antioxidant defend mechanism.
 Jauniaux et al.11 suggested the theory of how the free radical is higher in abortion than in normal pregnancy.
They found that the intervillous O2 flow appeared much earlier in the abortion group so it can lead to excessive
free radicals production that can cause abortion11.
 The oxidative stress during pregnancy occurs in response to the fetoplacental energy demand. How the oxidative
stress cause an abortion have been studied by other study. Many mechanisms have been proposed as the theory.
Zhu et al.12, suggested three factors that has an impact on the pathogenesis of abortion. First, the ROS can cause
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the lipid peroxidation injury in the embryo. Second, the increasing free radicals can change oxygen partial
pressure in embryonic cells. And the last, increased of free radicals can lead to ischemia-reperfusion injury in the
fetus12.
 Actually, increased of antioxidants activity also found in early healthy pregnancy. These indicate that the
oxidative stress actually also occurs in normal pregnancy but the sufficient antioxidants are defended the free
radicals and prevented the damage6,13,14. In this study, the mean activity of CAT enzyme of incomplete
abortion was lower than normal pregnancy and threatened abortion (p<0.05). It means that there were
differences between the CAT enzyme activity in incomplete abortion, threatened abortion and normal pregnancy.
It was suggested that the excess of free radicals and the decreased of antioxidants in this study were associated
with the abortion.
 Sugino et al.6 found that CAT total activity was decrease
 and prostaglandin F2α synthesis was increase in decidua in cases of spontaneous abortion with vaginal bleeding.
They proposed that the termination of pregnancy was caused by decreasing activity of CAT which stimulates the
synthesis of prostaglandins6. This study was accordance with the study by Yigenoglu et al.15 that found the total
antioxidant capacity is lower in pregnant women with history of spontaneous abortion than healthy pregnant
women. It also accordance with a study conducted by Biri et al.16 that found the CAT activity was higher in
abortion group than in control group (87.62±8.19 vs
 44.47±3.79 IU mgG1).
 CONCLUSION
 Abortion group had lower antioxidant concentration and higher free radicals than normal pregnancy. There was
an imbalance of free radical and antioxidant concentration in abortion.
 SIGNIFICANT STATEMENT
 The imbalance of free radical and antioxidant has been proposed to one of many theories that can cause abortion.
This study tried to determine the comparison of antioxidant and free radical level by analyzed the catalase
activity and malondialdehyde concentration in normal pregnancy and
 abortion. Malondialdehyde (MDA) is a metabolite of lipid peroxides that used as an indicator of lipid
peroxidation as a free radical. Meanwhile, catalase is one of antioxidant that works as free radicals binding by
preventing lipid peroxidation in the cell membrane. The result of this study will determine the imbalance of free
radicals and antioxidants in abortion and will help the medical field to develop the prevention of abortion.
